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Efficacy of Statin Therapy in the Prevention of Atrial Fibrillation
in Patients after Coronary Artery Bypass Grafting
OLGA L. BOCKERIA,1 VLADIMIR A. SHVARTZ,1 ALBERT A. AKHOBEKOV,1 ZALINA F. KUDZOEVA,1
ANTON R. KISELEV,1 ELENA Z. GOLUKHOVA,2 LEO A. BOCKERIA3
From 1Department of Surgical Treatment for Interactive Pathology, Bakoulev Scientific Center for Cardiovascular
Surgery; 2Corresponding Member of Russian Academy of Sciences, Nonivasive Arrhythmology Department, Bakoulev
Scientific Center for Cardiovascular Surgery; 3Academician of Russian Academy of Science, Director of Bakoulev
Scientific Center for Cardiovascular Surgery, Moscow, Russia
BOCKERIA ET AL.: Efficacy of Statin Therapy in the Prevention of Atrial Fibrillation in Patients after Coronary
Artery Bypass Grafting: Statin medication has shown good results in the prevention of the postoperative atrial
fibrillation (AF) after coronary artery bypass grafting (CABG). Objective: To assess the role of statin medication in
the prevention of AF after CABG. Material and Methods: A retrospective analysis of 225 medical records of the
patients, aged 57.5±7.9 years (mean±SD), who underwent CABG. All patients was divided into two groups. The first
group included those patients who did not received statin medication (n=93). We named this group as nSt-patients.
Second group included patients who receive statin medication (n=132). We named this group as St-patients. Clinical
data on all included patients were obtained in pre-, intra- and postoperative periods. The risk of occurrence of
postoperative AF was evaluated using the Cox-regression model. Continuous variables were reported as medians
(Me) with inter-quartile ranges (Q1, Q3). Categorical data were presented as percentages. Results: The rate of AF was
29% in nSt-patients and 9% in St-patients (P<0.001). On Day 4 after surgery, white blood cells (WBC) count was
10.9 (9.0, 13.0) ×109 e/L in nSt-patients and 9.1 (7.6, 10.0) in St-patients (P<0.001). An analysis of WBC count dayto-day changes was performed in a subgroup of patients who developed postoperative AF. This analysis showed that
the peak WBC numbers occurred on the day of arrhythmia manifestation. In this subgroup, WBC count increased
from 10.4 (7.5, 12.3) on Day 1 after surgery to 10.9 (9.0, 13.0) ×109 e/L on the day of onset of AF (P=0.008).
According to the Cox-regression model, the risk of AF was 3.68 for prior AF and 0.31 for statin medication. Conclusion:
In our study, we showed an association between the use of statin medication and AF in early postoperative period.
(J HK Coll Cardiol 2016;24:1-10)
Atrial fibrillation, Coronary artery bypass grafting, Postoperative period, Risk factors, Statin medication
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109 e/L

P=0.008
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Introduction
Atrial fibrillation (AF) is the most common
rhythm disorder occurring after coronary artery bypass
grafting (CABG). AF occurs in 25 to 30% of patients
after CABG.1-4 The onset of AF is associated with a high
risk of postoperative complications, such as
hemodynamic instability, stroke and myocardial
infarction. All these complications lead to prolonged
hospital stay and large economic cost.5-7
Some researchers recommend amiodarone and
beta-blockers to reduce the risk of postoperative AF.8-10
However, it should be noted that such preventive therapy
does not seem to be safe in all patients because of adverse
effects of these drugs, such as hypotension and
bradycardia associated with beta-blockers and
proarrhythmogenic effect of amiodarone. 11 The
difficulties in the prevention of AF after CABG is
explained by a poor understanding of both the
mechanisms of onset of AF in patients after the surgery
and the impact of intraoperative and postoperative
factors on the electrophysiological properties of the
atria.5,12
Any cardiac surgery is associated with an
inflammatory process that includes systemic and local
inflammation. 13,14 CABG is associated with the
increasing of the inflammatory markers, such as Creactive protein and interleukin-6, 13 with a peak
concentration on day 2 to 4 after the surgery, just when
the postoperative AF morbidity achieves its highest
rate.13,15 Inflammation is supposed to be a cause of the
AF by affecting as structural as electrophysiological
properties of the atria.16
In a number of previous studies, statin therapy
has been shown to be effective in prevention of the AF
after CABG. 16-19 The reduction in CABG-related

2

10 9 e/L

St-

P<0.001
10.4

10.9 9.0, 13.0
0.31

9.0, 13.0

7.5, 12.3
AF 3.68

inflammatory markers was noticed when statins were
used routinely prior and after the surgery.13,20,21 However,
other studies failed to demonstrate an antiarrhythmic
affect of statins after open-heart surgery.22-24
The objective of this study is to assess the role of
statin therapy in the prevention of the AF after GABG.

Material and Methods
General Design of Study
Design of this study was approved by the Ethics
Committee (Protocol no.9, 07 February 2014) of the
Bakoulev Center for Cardiovascular Surgery in Moscow,
Russia.
The data on the health status of all consecutive
patients with CABG were gathered retrospectively in
the Department of Surgical Treatment for Interactive
Pathology, Bakoulev Scientific Center for
Cardiovascular Surgery (Moscow, Russia). Informed
consent was obtained from all participants.
The following inclusion criterion was established
for the purposes of the study: isolated CABG performed
in 2013.
The patients were not included in our study if
they matched the following criteria:
i) Concomitant surgery (e.g. CABG with valve repair/
prosthesis, CABG with aneurysmectomy, CABG
with Maze-procedure, CABG with surgical
correction of ventricular septal defect)
ii) Severe renal failure (creatinine clearance
calculated by the Cockroft-Gault formula <50 mL/
min)
iii) Hypo- or hyperkalaemia
iv) Left ventricle ejection fraction (LVEF) <35%
v) Thyroid dysfunction (hyper- or hypofunction)
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vi) Other hormonal disorders
vii) Immunosuppressive and anti-inflammatory
medications for the treatment of comorbid
conditions
viii) Cancer
ix) Organic disorders of central nervous system
x) Psychological disorders
After selection, all patients were identified into
two groups.
The first group was composed of patients without
statin therapy neither prior nor after the CABG. We
named this group as nSt-patients.
The second group was composed of patients who
have statin therapy for at least 3 days prior to the CABG
and continuously after the operation. We named this
group as St-patients. Period 3 days was defined randomly
according to the literature data. It is supposed that antiinflammatory effect of statins begins to appear after 3
days of starting the therapy.19 In our study only original
atorvastatin and rosuvastatin were used. We made no
reckoning of the dose of statins.

postoperative periods. The source of patient's data is a
hospital chart.

Outcomes
AF event after CABG was endpoint of presented
study.
A postoperative AF event was defined an AF
episode lasting for more than 5 minutes occurred
postoperatively in the period 7 days after CABG. In
accordance with the study protocol and clinically
appropriate, all patients were under 24-hour bedside
electrocardiography and blood pressure (BP) monitoring
for the first 96 hours after the surgery. AF episode was
confirmed on the evidence of the above data.

Patients
In 2013, 415 CABGs were performed in
Department of Surgical Treatment for Interactive
Pathology, Bakoulev Scientific Center for
Cardiovascular Surgery (Moscow, Russia). Our
retrospective study included medical records on 225
patients with coronary heart disease (CHD) (196 men
and 29 women), aged 57.5±7.9 years (mean±SD), who
underwent CABG in in 2013. Two hundred and sixteen
patients were excluded from the study because of
nonfulfilment of the enrollment criterions. Workflow
of patients' selection is presented in Figure 1.
Healthy status of all included patients was
confirmed by the results of clinical investigation.
Finally, we have identified 93 (41%) nSt-patients
and 132 (59%) St-patients.

Data Collection
Clinical data (results with data physical
examinations, instrumental and laboratory
investigations) on all included patients were obtained
during their hospital treatment in pre-, intra- and

J HK Coll Cardiol, Vol 24

Figure 1. Patients' selection in this study.
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Statistical Analysis
We apply the Shapiro-Wilk test to check whether
the data were approximately normally distributed.
Continuous variables were reported as medians (Me)
with inter-quartile ranges (Q1, Q3) for non-normal data
or mean (M) with standard deviation (SD) for normal
data. Categorical data were presented as frequencies and
percentages. To compare the variables between the
patients' groups we used the Mann-Whitney test. The
difference between the two proportions was assessed
by t-test. Pared values were evaluated using Spearman's
correlation (R). The risk of occurrence of postoperative
AF was evaluated using the Cox-regression model. The
obtained estimations were considered statistically
significant if P<0.05.
We used the software package Statistica 10.0
(StatSoft Inc., Tulsa, Oklahoma, USA) for statistical
analysis.

AF postoperatively. The analysis showed that peak
WBC concentrations occurred on the day of onset of
arrhythmia (Figure 3). In this subgroup, WBC count was
10.4 (7.5, 12.3) ×109 e/L on Day 1 after surgery and
12.3 (10.0, 14.0) ×109 e/L on the day of onset of AF
(P=0.008). The difference remained significant.
The risk of occurrence of postoperative AF was
evaluated using the Cox regression model (Table 2). The
indicators with high correlation we not included together
in the analysis. Such factors as «Prior AF» and
«Antiarrhythmic therapy», «Prior MI» and «Therapy
with beta-blockers» and «Therapy with ACE-Is» had
high correlation (R<0.7). So only «Prior AF», «Prior
MI» were included in the analysis.
Of these clinical variables included in Cox
regression model, only prior AF and statin medication
use were found to be statistically meaningful for the
risk of AF after CABG. Results of the evaluation of the
risk of AF in this study are given in Table 3.

Results

Discussion

The studied groups of St-patients and nSt-patients
were comparable most anthropometric, clinical,
instrumental and laboratory characteristics in pre-, intraand postoperative periods. The relevant data for both
groups are presented in Table 1. Significant differences
between groups were found in the rate of AF and blood
leucocytes in the early postoperative period. AF
occurred in 29% of nSt-patients vs 9% in St-patients
(P<0.001).
There was no significant difference in the length
of hospital stay between groups: 9 (7, 11) in nSt-patients
vs 9 (7, 11) in St-patients (P=0.351).
Also, there was a difference between groups in
laboratory values: on Day 4 after surgery, white blood
cells (WBC) count was 10.9 (9.0, 13.0) ×109 e/L in nStpatients and 9.1 (7.6, 10.0) ×109 e/L in St-patients
(P<0.001). On Day 1, WBC count was also lower in Stpatients but the difference was insignificant (P=0.391)
(Figure 2).
AF paroxysms occurred earlier in nSt-patients
than in St-patients: Day 2 (2, 3) vs. Day 3 (3, 5),
P=0.039.
An analysis of WBC count day-to-day changes
was performed in a subgroup of patients who developed
4

Blood WBC as inflammatory markers were
chosen for our study as showing high prognostic value
for the onset of AF.25-27 Some previous studies have
shown neutrophils level more specific as an independent
predictor of postoperative AF.26 It is known that during
cardioplegia and bypassdue to ischemia and reperfusion,
neutrophils are involved and secrete a wide variety of
inflammatory biomarkers.
This study shows a strong correlation between
blood WBC count and the risk of postoperative AF: the
rate of AF was significantly higher in patients with a
higher WBC count. Furthermore, peak WBC
concentrations were observed on the day of onset of
AF.
Statin medication prior to CABG and in the
postoperative period was associated with reductions in
the rate of postoperative AF and blood WBC count. In
St-patients, peak blood WBC count occurred later than
in nSt-patients. In our study, the delay was 1 day. The
anti-inflammatory effect of statins seems to be due to
their pleiotropic properties. A considerable reduction of
the activity of all inflammatory markers under exposure
to 3-hydroxy-3-methyl-glutaryl-CoA (HMG-CoA)
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Table 1. Anthropometric and clinical characteristics of studied patients
Parameter
Age, years, M±SD
Male sex, no. (%)
Body weight, kg, M±SD
BMI, kg/m2, M±SD
Smokers, no. (%)
Hypertension, no. (%)
Prior MI, no. (%)
Diabetes, no. (%)
Prior CVA, no. (%)
CRF, no. (%)
Prior AF, no. (%)
Euro SCORE II, Me (Q1, Q3)
Prior antiarrhythmic therapy, no. (%)
Prior PCI, no. (%)
Prior therapy with ACE-Is, no. (%)
Prior therapy with beta-blockers, no. (%)
LAD, cm, Me (Q1, Q3)
EDD, cm, Me (Q1, Q3)
EDV, mL, Me (Q1, Q3)
EFLV, %, Me (Q1, Q3)
Preoperative potassium, mmol/L, Me (Q1, Q3)
Preoperative WBC, x109/mL, Me (Q1, Q3)
Preoperative creatinine, mmol/L, Me (Q1, Q3)
Off-pump CABG, no. (%)
On-pump CABG, no. (%)
CPB time, min, Me (Q1, Q3)
Aortic cross-clamping time, min, Me (Q1, Q3)
APV time, h, Me (Q1, Q3)
Number of grafts, Me (Q1, Q3)
RCA bypass, no. (%)
Graft thrombosis, no. (%)
Cessation of cardiotonic support, days, Me (Q1, Q3)
Postoperative AF, no. (%)
Day of AF onset, Me (Q1, Q3)
WBC count on Day 1, x109/mL, Me (Q1, Q3)
WBC count on Day 4, x109/mL, Me (Q1, Q3)
WBC count on the day of AF onset, x109/mL, Me (Q1, Q3)
Postoperative pneumonia, no. (%)
Number of bed-days, Me (Q1, Q3)
Intensive unit bed-days, Me (Q1, Q3)
Antiarrhythmic therapy, no. (%)
Therapy with ACE-Is, no. (%)
Therapy with beta-blockers, no. (%)

nSt-patients (n=93)

St-patients (n=132)

P-level

58.1±8.2
81 (87.1)
83.0±12.8
28,2±4.8
30 (32.3)
72 (77.4)
58 (62.4)
9 (9.7)
1 (1.1)
28 (30.1)
8 (8.6)
1.87 (0.94, 2.15)
8 (8.6)
3 (3.2)
91 (97.8)
92 (98.9)
4.1 (3.9, 4.5)
5.4 (5.0, 5.7)
135 (124, 159)
60 (54, 63)
4,1 (3.7,4.3)
9.9 (6.9, 10.1)
93 (83, 103)
74 (79.6)
18 (20.4)
99 (45, 123)
56 (45, 66)
7 (4, 9)
2 (2, 3)
51 (54.8)
3 (3.2)
3 (2, 3)
27 (29.0)
2 (2, 3), n=27
10.4 (7.5, 12.3)
10.9 (9.0, 13.0)
12.3 (10.0, 14.1), n=27
3 (3.2)
9 (7, 11)
1 (1, 2)
8 (8.6)
93 (100)
92 (98.9)

57.1±7.6
114 (86.4)
83.1±11.1
28,3±4.1
53 (40.2)
94 (71.2)
74 (56.1)
11 (8.3)
3 (2.3)
37 (28.0)
8 (6.1)
1.87 (0.94, 2.15)
8 (6.1)
7 (5.3)
129 (97.7)
129 (97.7)
4.1 (3.9, 4.4)
5.3 (4.9; 5.5)
134 (115, 154)
60 (56, 64)
4,15 (3.8,4.3)
9.6 (7.3, 11.8)
93 (86.5, 102.5)
116 (87.9)
18 (12.1)
96 (65, 127)
57 (45, 66)
7 (4, 8)
2 (2, 3)
77 (58.3)
1 (0.8)
3 (2, 3)
12 (9.1)
3 (3, 5), n=12
9.5 (7.4, 12.0)
9.1 (7.6, 10.0)
14.0 (10.0, 14.0), n =12
7 (5.3)
9 (7, 11)
1 (1, 3)
8 (6.1)
132 (100)
130 (98.5)

0.491
0.872
0.744
0.723
0.221
0.299
0.166
0.537
0.504
0.735
0.126
0.754
0.201
0.453
0.951
0.773
0.791
0.111
0.202
0.411
0.841
0.412
0.958
0.063
0.631
0.342
0.715
0.854
0.746
0.603
0.161
0.055
<0.001
0.039
0.391
<0.001
0.960
0.452
0.351
0.910
0.201
1
0.943

BMI, body mass index; CVA, cerebral vascular accident; MI, myocardial infarction; CRF, chronic renal failure; ACE-Is, angiotensinconverting-enzyme inhibitors; LAD, left atrial diameter; EDD, end-diastolic dimension of left ventricle; EDV, end-diastolic volume of
left ventricle; EFLV, ejection fraction of left ventricle; CPB, cardiopulmonary bypass; APV, artificial lung ventilation; RCA, right
coronary artery; WBC, white blood cells.
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Figure 2. Blood WBC count in studied groups on Day 1 after
surgery and Day 4 after surgery.

Figure 3. Blood WBC count on Day 1 after surgery, and on
the day of onset of AF.

Table 2. Clinical variables used in the Cox model of regression for evaluation of the risk of occurrence of AF
χ2=38.42, P<0.001)
in patients after CABG (χ
Parameter
Statins
Prior AF
Number of grafts
Diabetes
EDD
Preoperative creatinine
Age
CRF
Prior MI
EF
Prior PCI
CPB time
Sex
etc.

Regression
coefficient β

Standard error

Risk index
Exp (B)

Wald test

P

-1.145
1.251
0.419
-1.088
0.453
-0.017
0.023
0.505
0.359
0.014
-0.462
-0.001
0.012

0.357
0.396
0.231
0.779
0.356
0.014
0.022
0.505
0.380
0.021
1.037
0.003
0.520

0.318
3.493
1.520
0.336
1.572
0.982
1.023
1.657
1.432
1.014
0.629
0.999
1.012

10.24
9.96
3.28
1.94
1.61
1.38
1.02
0.99
0.89
0.43
0.19
0.14
<0.01

0.001
0.002
0.070
0.163
0.204
0.238
0.310
0.317
0.344
0.510
0.655
0.706
0.981

Note. Statistically significant predictors (P<0.005) of postoperative AF and first 11 non-significant factors are summarized in
Table 2 (presented in descending order of significance). Other indicators included in the multiple analysis (Table 1) are not
presented in the Table 2.
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χ2=16.14, P<0.001)
Table 3. Evaluation of the risk of AF depending on statin medication and prior AF variables (χ
Risk factors
Statins
Prior AF
Yes
No
Yes
No

No
No
Yes
Yes

Risk of AF in accordance
with the Cox model of regression

Level of
AF risk

Rate of AF in
this study

0.31
1.00
1.15
3.68

Low
Moderate
High
Very high

6.5%
25.6%
50.0%
54.5%

reductase inhibitors seems to be due to their effect on
neutrophils: increasing apoptosis and enhancing cytokine
secretion. Chello et al. in their blind placebo-controlled
study showed that using simvastatin 40 mg/daily during
7 days after surgery reduced peak anti-inflammatory
markers count (interleukin 6 an 8). 28 The antiinflammatory effect of statins begins to appear before
their hypolipidemic effect. In our study, statin
medication started just in 3 days before the intervention
led to significant results in terms of prevention of
postoperative AF.
In our study, the regression analysis showed that
only two factors could have significant influence on the
onset of postoperative AF, which are prior AF and statin
medication. Moreover prior AF increases the risk of
postoperative AF significantly due to arrhythmogenic
cardiomyopathy while the statin medication significantly
decreased the risk of postoperative AF (P=0.001). In
accordance with the Cox model of regression, the risk
of AF was lowest (6.5%) in St-patients without a history
of AF, moderate (25.6%) in nSt-patients without a
history of AF, high (50%) in St-patients with prior AF
and very high (54.5%) in nSt-patients with a prior AF.
Marìn et al. obtained similar results in a study on
234 patients.29 In the multivariant analysis, statin therapy
was found to be associated with a reduction of the rate
of AF after GABG (HR 0.52, 95% CI 0.28; 0.96,
P=0.038). The TIMP-1/MMP-1 ratio (TIMP-1 is tissue
inhibitor matrix metalloproteinase-1, MMP-1 is matrix
metalloproteinase-1) in 24 h after GABG was higher in
patients without a history of AF (P=0.043). Statin
medication was associated with increases of both the
TIMP-1 level and TIMP-1 / MMP-1 ratio (P=0.027 and
P=0.036, respectively). It should be noted that, unlike
us, Marìn used TIMP-1 and MMP-1 as inflammatory
markers.
J HK Coll Cardiol, Vol 24

Kimura et al. showed experimentally that
fluvastatin could inhibit the activities of leukotriene B4
and platelet activation factor.30 The lipid-independent
anti-inflammatory effect was confirmed in an
experimental study performed by Scalia et al.31 who
observed an inhibiting effect of simvastatin and
cerivastatin on actin-mediated membrane polymerization
and integrin-binding molecules of CD 11a, CD 18 and
VLA-4.
As far back as 1999, Ikeda et al. found that
fluvastatin and simvastatin exert a considerable
inhibiting effect on angiotensin 2-induced secretion of
interleukin-6 in the culture of human SMCs. This effect
was accompanied by a reduction in the level of Creactive protein.32
In a few studies, it was shown that statin therapy
could lead to the decrease in the length of hospital stay
due to a reduction of the AF.5-7 We have not seen this in
our study.
No significant association between several
clinical characteristics (chronic renal failure, prior
myocardial infarction, etc.) and risk of AF after CABG
was shown. It was also shown in previous studies.33-35
Whereas there is different data on the influence of
chronic renal failure on the onset of postoperative AF
showing as significant association36,37 as well as no
association.38,39
Otherwise other studies have shown significant
association between postoperative AF after CABG and
left atrial parameters,40 perioperative intra-aortic balloon
pump use,41 which was not shown in our study. The
reason may be due to the design of our study, which is
reflected in the Limitations section.
Postoperative pneumonia according to some
authors was also associated with postoperative AF.42 In
our study it was a rare complication. Moreover the
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statistical analysis was presented for pre- and
intraoperatively characteristics, so the influence of postoperative pneumonia could not be evaluated according
to the design of the study.

Conclusion
AF is one of potential complications that can
cause hemodynamic instability in patients after GABG
and increase the risk of stroke and postoperative
mortality. In our study, we showed an association
between the use of statin medication and AF in early
postoperative period. Anti-inflammatory properties
demonstrated by statins are one of the factors that may
explain why their beneficial effects on the clinical course
and prognosis of the atherosclerotic vascular disease are
more pronounced than could be expected.

Limitations
There are some limitations of our study. The main
one is related to the design. As it was retrospective trial,
there was no randomization and placebo-control.
It is known that all the patients with coronary
artery disease should get statin medication according to
the updated ESC/ACC/AHA guidelines. And if conduct
prospective randomized trial half of the patients are
supposed to discontinue the lipid-lowering therapy. In
our opinion it is impossible from the ethical position
according to the modern recommendations. In a
retrospective design of the study we were able to enroll
the patients who were not taking statins for other reasons
(social factors, economic factors, etc.).
It should be noticed that the authors did not
analyze the reasons for not receiving statin therapy prior
to the surgery. The study was retrospective and to
perform CABG there is no need for patients to receive
statin therapy. Statin medication and lipid levels control
is usually within the outpatient cardiologists cognizance.
In addition, it is known, that outpatient treatment
compliance is still unsolved problem.
In the presented study we have not evaluated the
influence of different doses and duration of statin therapy
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due to lack of retrospective information. Chen et al.43
evaluated the correlation between statin therapy
effectiveness in postoperative AF prevention and
different doses and duration of the therapy. Analysis has
shown statistically significant association between the
duration of preoperative statin therapy and risk of
postoperative AF, but no significant association was
show between statin doses and lower risk of
postoperative AF.
The main limitation of the study was no
information about serum lipid profile before the
operation, so the information was not included into the
analysis. So we have no statistically significant data to
propose that the anti-fibrillatory effect of statin extend
beyond its lipid lowering action.
Such factors as «Prior AF» and «Antiarrhythmic
therapy», «Prior MI» and «Therapy with beta-blockers»
and «Therapy with ACE-Is» had high correlation
between each other (R<0.7) and so were excluded from
the analysis.
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Arrhythmia in Severe Fever with Thrombocytopenia Syndrome
VIROJ WIWANITKIT
From Hainan Medical University, China; Joseph Ayobabalola University, Nigeria; University of Nis, Serbia; Dr DY
Patil Medical University, India; Surin Rajabhat University, Thailand
WIWANITKIT: Arrhythmia in Severe Fever with Thrombocytopenia Syndrome: There are many new emerging
infectious diseases in the present day. In cardiology, the important concern is on the cardiac presentation of any new
disease. Severe fever with thrombocytopenia syndrome is a new disease firstly reported from China and becomes the
important emerging infection in East Asia at present. The disease is proved to be due to the new severe fever with
thrombocytopenia syndrome virus, a newly identified pathogenic Bunyavirus, infection. This disease usually presents
with high fever and thrombocytopenia. Focusing on cardiac presentation, it is evidenced that the cardiac arrhythmia
can be observed in this new disease. Here, the author tries summarizing the observed arrhythmia in abnormal
electrocardiograms from available 3 reports. Of 109 patients who got electrocardiography studies, 27 cases (24.8%)
had arrhythmia. Focusing on the types of arrhythmia, there are sinus bradycardia (n=5), supraventricular arrhythmias
(n=8), premature ventricular beats (n=5), atrial fibrillation (n=7), atrioventricular block (n=2), right bundle branch
block (n=1) and ventricular fibrillation (n=1). Based on this summarization, the rate of arrhythmia in the patient with
severe fever with thrombocytopenia syndrome is very high and there are several forms of possible arrhythmia in the
patients. Sometimes, afebrile cases of severe fever with thrombocytopenia syndrome can be seen and the arrhythmia
might be the chief complaint of the patient. In the present day with, good international transportation, the cardiologist
has to keep in mind on the possibility of severe fever with thrombocytopenia syndrome in any patient with arrhythmia.
(J HK Coll Cardiol 2016;24:11-13)
Arrhythmia, Fever, Presentation, Severe, Thrombocytopenia
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Introduction
Infection is an important group of medical
disorder. There are many new emerging infectious
diseases in the present day. The good examples are
emerging atypical influenza virus infections, new Ebola
disease and Middle East Respiratory Syndrome
(MERS). In cardiology, the important concern is on the
cardiac presentation of any new disease. The occurrence
of cardiac arrhythmia in new emerging infectious disease
is very interesting. Recently, Wiwanitkit reported the
concern on cardiac arrhythmia induced by new Ebola
disease.1 It is no doubt that the cardiac arrhythmia can
be a forgotten clinical feature in the new disease.1
Here, the author will specifically focuses interest
on the new disease, "severe fever with thrombocytopenia
syndrome". Severe fever with thrombocytopenia
syndrome is a new disease firstly reported from China
and becomes the important emerging infection in East
Asia at present. The disease is proved to be due to the
new severe fever with thrombocytopenia syndrome
virus, a newly identified pathogenic Bunyavirus,
infection.2 This disease usually presents with high fever
and thrombocytopenia. 3 Focusing on cardiac
presentation, it is evidenced that the cardiac arrhythmia
can be observed in this new disease.

Materials and methods
This short study is a retrospective analysis on the
clinical data on cardiac arrhythmia seen in cases with
severe fever with thrombocytopenia syndrome. The
author used the standard database (PubMed and
SCOPUS) search for finding the publication on severe
fever with thrombocytopenia syndrome. The reports
with complete data on electrocardiogram were recruited
for further detail analysis.

Results
Here, the author tries summarizing the observed
arrhythmia in abnormal electrocardiograms from
available 3 reports. 1,4,5 Of 109 patients who got
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electrocardiography studies, 27 cases (24.8%) had
arrhythmia. Focusing on the types of arrhythmia, there
are sinus bradycardia (n=5), supraventricular
arrhythmias (n=8), premature ventricular beats (n=5),
atrial fibrillation (n=7), atrioventricular block (n=2),
right bundle branch block (n=1) and ventricular
fibrillation (n=1).

Discussion
Severe fever with thrombocytopenia syndrome
is a new problematic infectious disease. It is a main
concern in China and East Asia at present.3 The disease
is a new emerging viral tick-borne zoonosis.3,6 Also, the
direct human to human contact has recently been
reported as a mode of disease transmission.6,7 This new
disease has a wide clinical spectrum. Li reported
that the main clinical features of severe fever with
thrombocytopenia syndrome include "high fever,
thrombocytopenia, leukocytopenia, gastrointestinal
disorders, and multi-organ dysfunction, with a high viral
load and a high case-fatality rate".6 Nevertheless, in some
cases, it might be asymptomatic8 and there is usually
no hemorrhagic complication despite severe
thrombocytopenia.9 In an unusual cases, atypical clinical
presentation such as neurological presentation can be
seen.10
Focusing on cardiac problem in severe fever with
thrombocytopenia syndrome, Wiwanitkit reported that
T wave disorder was common in the patients with
this syndrome indicating possible direct cardiac
involvement. 11 Here, the author summarize on the
arrhythmia problem in cases with severe fever with
thrombocytopenia syndrome. In the study, the author
found cardiac arrhythmia in about ¼ of cases. Based on
this summarization, the rate of arrhythmia in the patient
with severe fever with thrombocytopenia syndrome is
very high and there are several forms of possible
arrhythmia in the patients. Sometimes, afebrile cases of
severe fever with thrombocytopenia syndrome can be
seen and the arrhythmia might be the chief complaint
of the patient.4
Cardiac arrhythmias in the subjects might be
secondary to many confounders, apart from the direct
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effect of severe sepsis related to Bunyavirus infection.
Confounding variables which could precipitate cardiac
arrhythmias are electrolyte disturbance, cardiac
enzymes, underlying pre-existing structural heart
diseases, thyroid dysfunction, hemodynamic status
(e.g. any septic or cardiogenic shock), ventricular
function, LA sizes, etc. However, these data are usually
not mentioned in the summarized reports. Nevertheless,
focusing on the reported baseline epidemiological
parameters of patients (age range 17-77 years old,
average 55.2 years),1,4,5 most of the patients are more
than 50 years old and have the risk of possible
underlying cardiovascular problem. Hence, the problem
is likely to be the secondary effect of hemodynamic
instability and septicemia. Focusing on the possibility
of direct effect of Bunyavirus infection (e.g. viral
myocarditis, direct viral infiltration of conduction
system), there has never been report on viral induced
cardiac histopathology in cases of severe fever with
thrombocytopenia syndrome. Nevertheless, the problem
due to other Bunyavirus in animal model is observed.12
The cardiac pathology in severe fever with
thrombocytopenia syndrome has to be further
systematically studied. Another myth on this topic that
can be further research topic is the response of cardiac
arrhythmia to pharmacological therapy. Indeed, ribavirin
treatment is mainly used for management of the case,
however, there is no report on observation on the cardiac
arrhythmia.

Conclusion
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In the present day with, good international
transportation, the cardiologist has to keep in mind on
the possibility of severe fever with thrombocytopenia
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Reaching an Unreachable Left Main Coronary Ostium in a Patient
with Dilated Aortic Root
KWOK-LEUNG WU AND KIN-LAM TSUI
From Department of Medicine, Pamela Youde Nethersole Eastern Hospital, Hong Kong
WU AND TSUI: Reaching an Unreachable Left Main Coronary Ostium in a Patient with Dilated Aortic Root.
This case report describes the use of an extended guiding system with an anchoring coronary guidewire to facilitate
diagnostic coronary angiography and subsequent coronary stent delivery in a patient with severe aortic regurgitation
and dilated aortic root. (J HK Coll Cardiol 2016;24:14-17)
Aortic, Coronary, Left, Main, Regurgitation

Introduction
Catheterizations of the coronary ostia in patients
with dilated aortic roots are technically demanding
which may require special techniques. We describe the
use of an extended guiding system with an anchoring
coronary guidewire to facilitate diagnostic coronary
angiography and subsequent coronary stent delivery.

Case
A 83-year-old male was admitted for non-ST
segment elevation myocardial infarction (NSTEMI) in
March 2015. He was an ex-smoker and he had past
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history of essential hypertension. He presented with
angina at rest. 12 lead electrocardiogram was performed
after admission which showed ST segment depression
over V3-6. Serum troponin I level was elevated to
11 ng/mLitre (<0.03 ng/mLitre). Echocardiogram
showed dilated aortic root, and the dimensions of aorta
at the level of aortic sinus and sinotubular junction
measured at the parasternal long axis view were
5.19 cm and 5.14 cm respectively (Figure 1). Severe
aortic regurgitation was noted at multiple views
(Figure 2). The left ventricular ejection fraction was
53 percent. Medical treatment for NSTEMI was initiated
which included aspirin, clopidogrel and low molecular
weight heparin, however patient had persistent
angina. Therefore the potential need of coronary
revascularization was explained to patient, which
included the option of coronary artery bypass graft
(CABG) for possible obstructive coronary artery disease
and concomitant aortic valve replacement for severe
aortic regurgitation. However patient refused open heart
surgery. He only accepted percutaneous route of
coronary revascularization.

April 2016

J HK Coll Cardiol, Vol 24

WU AND TSUI

We proceeded to coronary angiogram via the right
radial artery using the 6 F sheath. Engagement of the
left main coronary artery ostium was difficult with 5 Fr
Tiger II Catheter (Terumo) as the aortic root was dilated.
Therefore selective angiogram of right coronary artery
(RCA) was performed first by the same diagnostic
catheter, which showed chronic total occlusion over the
middle segment of RCA. Subsequent engagement of the
left main coronary artery was failed by 6Fr Judkin's Left
3.5, 4, 5 and 6 diagnostic catheters (Cordis). In this
regard, we performed non-selective contrast injection
over the coronary sinus which could only vaguely
delineate the left main coronary artery ostium and
apparently an obstructive lesion was seen over the
proximal segment of left anterior descending artery

Figure 1. Dilated aortic root from parasternal long axis view.

Figure 2. Dilated aortic root with severe aortic regurgitation
from apical five chamber view.
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(LAD). We then tried cannulation of left main coronary
artery by 6Fr Amplatz Left 1, 2, 3, 6F Extra Back Up 4,
4.5, and 6Fr Multipurpose diagnostic catheters (Cordis)
but we were still in vain.
As the left main coronary artery ostium was
unreachable via the right radial artery, we switched the
access site to the right femoral artery. A 7Fr femoral
sheath was inserted. Again, engagement by 7Fr Extra
Back Up 4 and 4.5 guide catheters and 6Fr Multipurpose
guide catheter (Medtronic) were all failed. Wiring of
ostium was then attempted by NS Runthrough coronary
guidewire (Terumo) through the unengaged guide
catheter, but such strategy was unsuccessful even after
insertion of J-tipped 0.035 inch wire to change the
configuration of the guide catheter (Figure 3).
After that, a 7Fr GuideLiner catheter (Innotronik)
was inserted which extended the working length of the
7Fr Extra Back Up 4.5 guide catheter but cannulation
of the left main coronary artery ostium was still
unsuccessful. This extended guiding system, however,
could be manipulated closer to and orientated more
towards the left main coronary artery ostium. With this
extended guiding system, attempts were made to
manipulate the NS Runthrough coronary guidewire
(Terumo) into the left coronary artery, but it was still
difficult (Figure 4). Yet after repeated manipulation of
the guiding system and its orientation, the coronary
guidewire subsequently could reach the left main
coronary artery ostium and passed downstream into left
anterior descending artery (Figure 5).
The extended guiding system was then tracked
over the coronary guidewire and engaged into the left
main coronary artery ostium. Selective angiogram
confirmed a significant stenosis over the proximal
segment of LAD, which was pre-dilated by 2.5 mm by
15 mm Sprinter Legend balloon (Medtronic) and stented
by 4.0 mm by 18 mm Resolute Integrity drug eluting
coronary stent (Medtronic) (Figure 6). The patient was
discharged with stable condition on the next day after
the procedure. We planned to arrange thallium scan to
assess the functional significance of the chronic total
occlusion over the right coronary artery in order to
decide the need of further intervention.
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REACHING AN UNREACHABLE LEFT MAIN CORONARY OSTIUM

Figure 3. Unsuccessful wiring (small arrow) of the left main
coronary artery (big arrow) by 7Fr EBU 4.5 guiding catheter
with the J-tipped 0.035 inch wire in-situ which served to
change the configuration of guide catheter.

Figure 4. The guiding system was extended by 7 Fr
GuideLiner catheter but wiring of the left main coronary artery
(straight arrow) was still difficult.

Figure 5. Successful wiring of the left main coronary artery
ostium (straight arrow).

Figure 6. Positioning of stent over the proximal segment of
left anterior descending artery.

16

April 2016

J HK Coll Cardiol, Vol 24

WU AND TSUI

Discussion
This patient presented with NSTEMI and 12 lead
electrocardiogram revealed myocardial ischemia over
the territory supplied by left anterior descending artery
(ST segment depression over V3-6). Apparently there
was an obstructive lesion over the proximal segment of
left anterior descending artery during non-selective
contrast injection over the coronary sinus. Therefore
percutaneous coronary intervention was warranted for
this patient who refused open heart surgery.
In dealing with difficult cannulations of coronary
ostia, if both diagnostic and guiding catheters were
failed, wiring by coronary wire through an unengaged
guiding catheter could be first considered. However,
such maneuver could be unsuccessful in patients with
dilated root because of the long distance between the
catheter tip and the coronary ostia. In such case,
telescopic technique1 can be a solution.
Previously described telescopic techniques
included both "four-in-six" system and "five-in-six"
system. The "four-in-six" approach utilizes a 4Fr,
125 cm Multipurpose diagnostic catheter (Cordis) inside
the 6Fr guide catheter. Whereas the "five-in-six"
approach utilizes a 5Fr Heartrail catheter (Terumo)
inside the 6Fr guide catheter.2
The GuideLiner catheter (Innotronik) is a co-axial
guiding catheter extension delivered through a standard
guiding catheter on a monorail system. It comprises of
a 20 cm polytetrafluoroethylene extension whose inner
diameter is 1 Fr size smaller than the guide catheter.
The main use of this catheter is to deliver stents in
tortuous coronary lesions by deep engagement and
providing better support.3
When GuideLiner catheter is used to facilitate
engagement of coronary ostium, it has an advantage over
the traditional telescoping catheter approach. Stent
delivery is possible with a 6Fr Guideliner catheter left
in-situ within a 6Fr guide catheter, but such strategy is
not possible with a 4 or 5Fr diagnostic catheter which
is inserted in a 6Fr guide catheter.
Roth et al. had described a case of successful left
main coronary artery ostium after guide system
extension by GuideLiner catheter in a patient with
dilated aortic root.4 However, in our case we still failed
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with this approach alone. Anchoring of the left main
coronary artery was only successful when this approach
was combined with manipulation of a coronary
guidewire into the left coronary artery through the
unengaged guiding system. Furuichi et al. has reported
a case using coronary guidewire with the aid of
telescopic catheter to achieve successful cannulation and
intervention of a right coronary artery with anterior takeoff.5 However, to our understanding the present case is
the first report employing Guideliner catheter and
coronary guidewire to accomplish cannulation of left
main coronary artery in a patient with dilated aortic root.
This technique has the advantage of allowing successful
intervention without the need of removing a telescopic
catheter.

Conclusion
Engagement of left main coronary artery ostium
could be difficult in patients with dilated aortic root. In
cases of failed cannulation by conventional methods,
use of extended guiding system with GuideLiner catheter
together with anchoring of a coronary guidewire into
the coronary ostium can bring success to reach this
unreachable coronary artery.
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HK COLLEGE OF CARDIOLOGY, TWENTY-FOURTH ANNUAL SCIENTIFIC CONGRESS
ABSTRACTS
Abstracts for Free Paper Session:
ISCHEMIC HEART DISEASE
In-hospital Management and Outcomes of Patients Hospitalized
with Acute Coronary Syndrome
KY Chan,1 KH Yiu,2 A Cheong,3 BP Yan1
1
Department of Medicine & Therapeutics, The Chinese University of Hong
Kong; 2North District Hospital; 3Alice Ho Miu Ling Nethersole Hospital,
Hong Kong
Purpose: Acute coronary syndrome (ACS) represents a heterogeneous
spectrum of conditions. This study aimed to evaluate baseline characteristics,
in-hospital management and outcomes in patients hospitalized with ACS.
Methods: We retrospectively analysed 5,987 consecutive patients admitted
with ACS between August 2010 and July 2015 to 3 hospitals in the Hong
Kong New Territories East Cluster. Data were collected by using the electronic
medical records of the Clinical Data Analysis and Reporting System of the
Hospital Authority. Multivariate logistic regression was performed to identify
independent predictors of in-hospital mortality.
Results: Of 5,987 patients, 29.8% had ST-segment elevation myocardial
infarction (STEMI), 70.2% had non-ST-segment elevation ACS (NSTEACS).
Overall, 62.0% were ≥65 years old, 65.4% male and 21.7% had diabetes.
Percutaneous coronary intervention (PCI) and coronary artery bypass surgery
were performed during index hospitalization in 73.7% and 0.3% STEMI and
53.2% and 1.0% NSTEACS patients, respectively. On discharge, dualantiplatelet therapy (clopidogrel 88.9%, prasugrel 3.2% and ticagrelor 7.8%)
was prescribed in 78.3% and 54.4% and statins (simvastatin 84.1%,
atorvastatin 8.4% and rosuvastatin 7.5%) in 84.6% and 76.9% of patients
with STEMI and NSTEACS, respectively. Low, moderate and high intensity
statins were prescribed on discharge in 17.2%, 69.8% and 13.0% of STEMI

Twelve-month Clinical Outcomes in Patients with Acute
Coronary Syndrome after Hospital Discharge
KY Chan,1 KH Yiu,2 A Cheong,3 BP Yan1
1
Department of Medicine & Therapeutics, The Chinese University of Hong
Kong; 2North District Hospital; 3Alice Ho Miu Ling Nethersole Hospital,
Hong Kong
Purpose: There is a paucity of data about the post-discharge outcomes and
contemporary management practices of patients with an acute coronary
syndrome (ACS) in Hong Kong. This study aimed to evaluate 12-month allcause mortality and major adverse cardiac events (MACE) in ACS patients.
Methods: We retrospectively analysed 4,405 consecutive patients admitted
and discharged with ACS between August 2010 and July 2014 to 3 hospitals
in the Hong Kong New Territory East Cluster using the electronic medical
records of the Clinical Data Analysis and Reporting System of the Hospital
Authority. Multivariate Cox regression was performed to identify independent
predictors of MACE.
Results: Of 4,405 patients, 1,242 (28.2%) patients had ST-segment elevation
myocardial infarction (STEMI) and 3,163 (71.8%) patients had non-STsegment elevation ACS (NSTEACS). Overall, 12-month post-discharge
mortality rate was 14.3%; 10.0% in patients with STEMI and 16.0% in
patients with NSTEACS. Rate of recurrent ACS was 9.4% during 12-month
follow-up; 5.2% and 11.0% in patients with STEMI and NSTEACS
respectively. Dual-antiplatelet therapy was prescribed in 22.6% (clopidogrel
87.5%, prasugrel 5.1%, and ticagrelor 7.4%) and statin in 74.8%
(simvastatin 81.2%, atorvastatin 8.4%, and rosuvastatin 10.3%) of patients
at 12-month follow-up. Independent predictors of 12-month MACE included
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and 32.1%, 61.3% and 6.6% of NSTEACS patients, respectively. In-hospital
mortality rates were higher among patients with STEMI than NSTEACS
(overall 11.0%; STEMI 14.6% vs. NSTEACS 9.5%; p<0.01). Independent
predictors of in-hospital mortality included age ≥65 years old (Odds Ratio
(OR), 2.79; 95% CI, 2.09 to 3.72; p<0.01), STEMI (OR, 3.42; 95% CI, 2.72
to 4.29; p<0.01), no PCI during index hospitalization (OR, 4.45; 95% CI,
3.37 to 5.87; p<0.01), and no statins during hospitalization (OR, 23.65, 95%
CI, 17.23 to 32.45, p<0.01).
Conclusions: This study demonstrated discordance between existing
guidelines for ACS and current practice in Hong Kong. Early revascularization
and prescription of statin before hospital discharge were strong predictors of
in-hospital survival.

age ≥65 years old (OR, 2.74; 95% CI, 2.23 to 3.36; p<0.01), diabetes mellitus
(OR, 1.26; 95% CI, 1.06 to 1.48; p=0.01), no DAPT upon discharge (OR,
1.93; 95% CI, 1.63 to 2.27; p<0.01), no DAPT at 12 months (OR, 1.48;
95% CI, 1.14 to 1.92; p<0.01), statin therapy on admission (OR, 1.38; 95%
CI, 1.17 to 1.62; p<0.01), and no statins at 12 months (OR, 1.20; 95% CI,
1.01 to 1.43; p<0.01).
Conclusions: Our results demonstrated that a considerable proportion of ACS
patients discharged from hospital remained at increased risk for adverse
outcomes. These data suggest the need for better long-term medical
management and more intense follow-up of patients with ACS to improve
their long-term outlook.
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HK COLLEGE OF CARDIOLOGY, TWENTY-FOURTH ANNUAL SCIENTIFIC CONGRESS
ABSTRACTS
Abstracts for Free Paper Session:
ISCHEMIC HEART DISEASE
Intermediate Lesions Prone to Progression and Revascularization:
PSCD Risk Score System and Therapy Strategies
RQ Yan, JL Chen, LJ Gao
State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National
Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences
and Peking Union Medical College, China

Population Attributable Risks of Modifiable Risk Factors
Incorporating lipoprotein (a) and Low Serum Albumin
Concentrations for First Incident Acute Myocardial Infarction
in Chinese Han Ethnic Population: Cross-sectional Study of 1552
Cases and 6125 Controls
YM He,1 Q Yang,2 XJ Yang,1 HF Xu,1 DP Cai3
Division of Cardiology, The First Affiliated Hospital of Soochow University;
2
Division of Cardiology, Department of Medicine & Therapeutics; 3Healthcare
Center for Shishan Street Community, Suzhou, China
1

Background: Effective early identification of which intermediate lesions
will be a candidate for revascularization over time, is of paramount
importance, providing the opportunity to implement therapy and prevention
strategies.
Methods: The study population comprised of 465 patients with 519
intermediate lesions who underwent angiography on initial admission and
angiographic follow-up ((11.02±5.84) months). According to whether these
intermediate lesions received a necessary revascularization or not during the
follow-up, the patients were classified into Revascularization group (162 of
182 lesions in 156 patients) and No revascularization group (337 lesions in
309 patients). Risk factors for revascularization of these intermediate lesions
were analyzed.
Results: Multivariate analysis of the risk factors of future revascularization
of intermediate lesions showed that type 2 diabetes (OR=1.616, 95% CI
1.058-2.470, P=0.026), no use of statins (OR=3.355, 95% CI 1.455-7.740,
P=0.005), complex lesions (OR=2.743, 95% CI 1.805-4.168, P<0.001) and
proximal lesions (OR=1.635, 95% CI 1.056-2.533, P=0.028) were independent
predictors. PSCD risk score was established and analyzed.
Conclusions: Intermediate lesions with high PSCD risk score, should be
considered for receiving more aggressive treatments involves coronary
revascularization.

Aims: Risk burdens of modifiable risk factors incorporating lipoprotein (a)
(Lp(a)) and low serum albumin (LSA) concentrations for first incident acute
myocardial infarction (AMI) haven't been studied simultaneously in Chinese
Han ethnic population.
Methods: Cross-sectional study of 1552 cases and 6125 controls was
performed for identifying the association of risk factors with first incident
AMI and their corresponding population attributable risks (PAR).
Results: Modifiable risk factors incorporating LSA and Lp(a) accounted for
up to 92% of PAR for first incident AMI. The effects of these risk factors are
different in women and men, across different age categories. Overall, smoking
and low serum albumin are the 2 strongest risk factors, together accounting
for 64% of PAR for first incident AMI. After multivariable adjustment, Lp(a)
and LSA have accounted for 19% and 41%, respectively, and together for
more than a half (54%) of PAR for first incident AMI. Unexpectedly,
hypertension is not significantly associated with first incident AMI.
Conclusions: Modifiable risk factors incorporating LSA and Lp(a) have
accounted for an overwhelming large proportion of the risk of first incident
AMI, indicating that most first incident AMI is preventable. Risk factor
intervention strategies should be tailed for different populations. The knowledge
of risk burdens for CAD in terms of Lp(a) and LSA concentrations may further
reduce first incident AMI in Chinese Han population from a new angle.

Association between Serum 25-hydroxyvitamin D and Carotid
Atherosclerotic Plaque in Chinese Type 2 Diabetic Patients
TH Ding, LY Qian, J Pang, H Zou
Zhejiang Provincial People's Hospital, China
Objective: The purpose of this study was to investigate the distribution of
vitamin D status and the association between vitamin D and carotid
atherosclerotic plaque (CP) in Chinese type 2 diabetic patients.
Methods: The cross-sectional study was performed among 210 type 2 diabetic
patients and 94 non-diabetic patients which are age- and gender-matched
during the winter months. Serum 25-hydroxyvitamin D [25(OH)D] was
examined in both diabetic and controls. B-mode ultrasonography of carotid
arteries was measured in type 2 diabetic patients.
Results: The concentration of 25(OH)D was 26.25(16.78-48.60) nmol/l
among diabetic patients. 93.3% diabetic patients were suffering from
hypovitaminosis D (76.67% for deficiency and 16.67% for sufficiency). We
confirmed a clear negative association between the concentration of
25(OH)D and CP in type 2 diabetic patients (p<0.001). Meanwhile, the
significant association between 25(OH)D and macrovascular disease was
observed (p=0.005). In multivariate logistic regression analysis, decreasing
concentration of 25(OH)D was found to be remarkably associated with CP in
type 2 diabetic patients, as well as old age (OR: 2.533, p=0.013), smoking
(OR: 3.872, p=0.001) and high level of LDL-c (OR: 2.776, p=0.009), after
adjusting for the confounding factors.
Conclusion: A high prevalence of hypovitaminosis D exists in Chinese type 2
diabetic patients. Low concentration of 25(OH)D is remarkably associated with
the presence of CP in diabetics. Besides, smoking, high level of BMI and
LDL-c are also substantially positive predictors of CP in type 2 diabetic patients.
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Bioresorbable Scaffold in Primary PCI through Transradial
Approach in a Bangladeshi Diabetic Population, a Single Center
Single Operator Study
SR Khan, CMS Kabir
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success with TIMI III flow was 95.6%. After 3 months follow up, no MACE
or death were recorded.
Conclusions: As it is a single operator study, the feasibility of using BVS in
STEMI patients was uniformly and homogeneously judged and proved to be
well feasible. The experience of using BVS in primary PCI was rather soothing
as edge response was quite comfortable for the operator.

Aims: Bioresorbable scaffold (Everolimus eluting) has some unique property
and its feasibility and compatibility specially in lesions causing acute ST
elevation MI is still an "under test" issue. In our relatively smaller study, we
have evaluated the procedural and 3 months follow up of the patients
undergoing PCI for acute STEMI through radial approach.
Methods: This is a single centre single operator prospective study since
February 2013 to January 2015. The patients with diabetes mellitus presented
with acute STEMI undergoing primary PCI were included. Target vessel
revascularization was done through left Radial approach by BVS implantation.
Primary endpoint was procedural success and angiographic TIMI flow.
Secondary endpoint was MACE or death within 3 months follow up. No
periprocedural IVUS or OCT imaging was done.
Results: Total 23 patients with DM were included in this period of study.
Sixteen (69.5%) were male and the rest 7 patients were female. Mean age
was 59±4.5 yrs. Out of 23, 19 patients (82.5%) were presented with acute
anterolateral STEMI. Angiographically TIMI 0 flow was observed in 5
patients. The rest 18 patients had TIMI I flow before PPCI. Four (17.5%)
patients were presented with Inferior MI. Target vessel revascularization was
done by deployment of BVS in LAD = 16 (69.5), LCx = 4 (17.3%) and RCA
= 3 (13.2%). Mean BVS diameter was 2.76±0.2 mm and mean stent length
was 23.2±2.5 mm. One patient with triple vessel disease was expired during
procedure while doing PCI to dominant LCx as the target vessel. Procedural

Duration of Dual Antiplatelet Therapy after Drug-eluting Stent
Implantation: Meta-Analysis of Randomized Controlled Trials

Y Fei, MF Tsoi, TT Cheung, BMY Cheung
Department of Medicine, The University of Hong Kong, Queen Mary
Hospital, Hong Kong
Purpose: Patients are recommended for 6-12 months' dual antiplatelet therapy
(DAPT) after drug-eluting stents (DES) implantation. The optimal duration
of DAPT which could make the most of clinical benefits while diminishing
related risks has always been debated. Previous meta-analyses comparing
short-term (<12 months) and extended durations (>12 months) of DAPT
showed no significant benefit for longer duration treatment but a significant
increase in the risk of bleeding. With the latest evidence, the optimal duration
of DAPT needs to be re-examined to guide clinical practice. We performed a
meta-analysis of randomized controlled trials to assess the risks and benefits
of diverse DAPT durations after DES implantation.
Methods: We performed literature search using MEDLINE, Scopus,
EMBASE, ISI Web of Science, Cochrane Library, ClinicalTrials.gov and
recent conference proceedings, and included those trials randomizing patients
to receive different durations of DAPT after DES implantation and reporting
frequency of cardiovascular and bleeding events. Statistical analysis was
performed using RevMan 5.3.4. Heterogeneity was calculated using I2
statistics; bias in the selection or publication of studies was assessed.
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Results: Eleven randomized controlled trials with 33520 patients were
included for analysis with 4 trials comparing extended DAPT vs. 12 months'
regimen and 7 trials comparing short-term DAPT vs. 12 months' regimen.
Compared to 12 months' DAPT treatment, extended DAPT significantly
reduced the frequency of myocardial infarctions (OR 0.54 95%CI: 0.430.66; p<0.00001) and stent thrombosis (OR 0.36 95%CI: 0.24-0.55;
p<0.00001), but the risks of major bleeding (OR 1.54 95%CI 1.22-1.96) and
all-cause mortality (OR 1.43 95%CI 1.14-1.81) were substantially increased.
There was no significant difference in preventing stroke, cardiac mortality
and repeat revascularization. Compared to short-term DAPT, 12-month DAPT
was associated with increased major bleeds (OR 1.98 95%CI: 1.26-3.11).
However, no significant difference was found in the risk of other primary
outcomes.
Conclusion: 12-month DAPT appears to be a reasonable compromise between
preventing stent thrombosis and increasing bleeding risk. Our meta-analysis
included both the largest DAPT trial and the most recent OPTIDUAL trial
yielded new conclusions. Extending DAPT beyond 12 month shows benefits
in reducing myocardial infarction and stent thrombosis, but with a concurrent
increase in major bleeding and all-cause, although not cardiovascular,
mortality. Discontinuation of DAPT before 12 months decreases the number
of major bleeds with no apparent difference in other primary endpoints. In
practice, this means that patients vulnerable to bleeding can have a short
duration of DAPT but for those who are not at risk of bleeding, extended
DAPT beyond 12 months can be considered.
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KY Chan,1 KH Yiu,2 A Cheong,3 BP Yan1
Department of Medicine & Therapeutics, The Chinese University of Hong
Kong; 2North District Hospital; 3Alice Ho Miu Ling Nethersole Hospital,
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Conclusions: Ticagrelor is increasingly used in ACS patients who underwent
early revascularization. Although antiplatelet therapy should still be
individualized based on the thrombotic and bleeding risk, our study highlights
the safety of the new P2Y12 inhibitors in contemporary Hong Kong practice.

1

Purpose: We aim to compare long-term clinical outcomes among acute
coronary syndrome (ACS) patients who underwent percutaneous coronary
intervention (PCI) using ticagrelor versus clopidogrel.
Methods: We retrospectively analysed 1,336 consecutive ACS patients who
underwent in-hospital PCI with drug-eluting stent (DES) implantation between
August 2010 and July 2014 to 3 hospitals in the Hong Kong New Territory
East Cluster using the electronic medical records of the Clinical Data Analysis
and Reporting System of the Hospital Authority. The primary outcome was
major adverse events (MACE) at 24 months. Univariate Kaplan-Meier
analyses were performed for incidence of outcomes and multivariate Cox
analysis was performed to identify independent predictor of MACE.
Results: Clopidogrel and ticagrelor were used in 1,235 (92.4%) and 101
(7.6%) patients. From 2010-2014, there was a trend towards ticagrelor from
5.1% to 16.9% by the end of the period. Patients treated with ticagrelor were
more likely to present with ST-elevation myocardial infarction (STEMI) and
younger. Unadjusted 24-month mortality (4.2% vs. 1.0%, p=0.17), recurrent
ACS (6.6% vs. 1.0%, p=0.03) and MACE (9.8% vs. 2.0%, p=0.01) were
higher in patients who received clopidogrel compared to ticagrelor. After
adjustment, ticagrelor remained an independent predictor of MACE free
survival (Adjusted Hazard Ratio (AHR), 0.19, 95% CI 0.04 to 0.97, p=0.05).
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Clinical Analysis of 25 Patients with Infective Endocarditis but
without Structural Heart Disease
L Hu, YF Li, ZW Zhang, G Xu, YM Xie, GH Zeng
Guangdong Cardiovascular Institute, China
Objective: To analyze the latest 5 years young patients with clinical
symptoms, laboratory tests, etiological examination, echocardiography,
complications, surgical treatment and prognosis, which had no structural heart
disease, and summarize the experience of treatment for this kind of infective
endocarditis.
Method: Retrospective analysis was performed on the patient without
structural heart disease in hospital from January 2010 to October 2015,
including their clinical features, surgical outcome and prognosis.
Result: 25 cases were collected, accounting for 22.12% of the infective
endocarditis patients (25/113), including 13 male and 12 female, the age
from 10 months to 18 years old. The main clinical manifestations were fever
(22, 88%), heart murmur (23, 92%). Left ventricular endocardial vegetation
was detected by echocardiography in all, and 2 combined with tricuspid valve
vegetation. Heart failure is the most common complications (68%), followed
by embolic events (24%), and then splenomegaly (8%). Streptococcus is the
main pathogenic bacteria, followed by Staphylococcus aureus. Twenty-four
cases were under surgical removal of vegetation and valve repair combined
with active internal anti infection treatment. Twenty-three patients were cured
(95%), except 1 patient with severe left heart failure, and died of low cardiac
output syndrome after surgery (4.16%). The other one had so long duration
that developed multiple systemic embolisms, multiple organ dysfunctions
and died at last.

Conclusion: The incidence rate of Patients with infective endocarditis without
structural heart disease is 22.12%, which should pay significance attention.
This kind of infective endocarditis usually accompanied with left heart
vegetation, which can result in heart failure and aggravate the patients'
condition. So when the patient with infective endocarditis have operation
indication, especially got left heart vegetation and heart failure ones, should
give active medical anti infection treatment and be operated as soon as possible
to get a better prognosis.

Infective Endocarditis in an Adult Female with Bicuspid
Aortic Valve, Hypertrophic Cardiomyopathy and Amyopathic
Dermatomyositis: A Case Report
AG Tojino, HFS Maria, RP Tiongco, MS Senadrin
St. Luke's Medical Center-BGC, Philippines
Purpose: Bicuspid aortic valve (BAV) and Hypertrophic cardiomyopathy
(HCM) are rare congenital heart diseases with prevalence in the general
population of 1% and 0.2% respectively. Connective Tissue Disease is a
group known to have various cardiac involvements to which Amyopathic
dermatomyositis belong.
Methods: We present a case of a 38-year-old female who came in with
abdominal pain, fever, skin hyperpigmentation and systolic murmur that was
diagnosed with splenic infarction secondary to Infective endocarditis.
Results: Transesophageal echocardiography revealed marked hypertrophy
and a nonmobile vegetation in a bicuspid aortic valve. Cardiac MRI revealed
asymmetric hypertrophy, marked LV wall thickness and Late Gadolinium
Enhancement fibrosis typically seen in Hypertrophic cardiomyopathy.
Conclusion: This is the first reported case of an adult female with Infective
endocarditis who presents with Bicuspid aortic valve, Hypertrophic
cardiomyopathy and Amyopathic dermatomyositis. We want to point out the
potential benefits of Cardiac MRI in establishing the diagnosis of patient's
marked hypertrophy as solely due to Hypertrophic cardiomyopathy and not
as a result of compensatory hypertrophy secondary to aortic stenosis. We
highlight the unusual combination of Hypertrophic cardiomyopathy and
dermatomyositis and the utility of Cardiac MRI in the definite diagnosis of
HCM with concomitant BAV.
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in Patients with Sporadic and Isolated Ventricular Septal Defect
HX Chen,1 X Zhang,1 HT Hou,1 J Wang,1 XL Wang,1 Q Yang,1,2 GW He1,3
Department of Cardiovascular Surgery & Center for Basic Medical Research,
TEDA International Cardiovascular Hospital, Chinese Academy of Medical
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1

Conclusions: We identified a novel heterozygous missense mutation in TBX5
gene exon-2 in sporadic and isolated VSD patients suggesting heterogeneous
nature of the sporadic VSD and the important role of HRM as a reliable and
efficient method to determine disease-related gene mutation in CHD. The
functional analysis suggests that mutation may increase the susceptibility to
the development of VSD as a risk factor.

Purpose: Ventricular septal defect (VSD) is the most frequently occurring
congenital heart disease (CHD) in newborns. A number of genetic studies
have linked TBX5 mutations to cardiac abnormalities. We aimed to identify
potential pathogenic mutations in TBX5 and to provide insights into the
etiology of isolated VSD.
Methods: Case-control mutational and functional analysis was performed in
354 sporadic patients with isolated VSD and 341 controls. All the coding
exons and intron-exon boundaries of TBX5 were first sequenced in a group
of VSD patients and controls. Sanger sequencing with high-resolution melting
(HRM) curve analysis in new patients and controls was then used to detect
TBX5 mutation and frequency. Luciferase activities were measured to identify
transcriptional regulation of TBX5 to MYH6 promoter.
Results: A novel heterozygous missense mutations (c.40C>A) was identified
in TBX5 gene exon-2. This mutation leads to proline to threonine substitution
at position 14, which is highly conserved among many species. TBX5
containing mutation displayed less transcriptional activation of the MYH6
promoter compared to wild type.

Risk Factors and Nursing Strategies of Transcatheter
Interventional Therapy for Congenital Heart Diseases based on
Big Data Analyses
QP Yan, LX Liu, C Liu, Y Wang
Department of Pediatric Cardiology, Guangdong General Hospital,
Guangdong Academy of Medical Sciences, Guangdong Cardiovascular
Institute, China
Purposes: Based on big data analyses, we discuss the risk factors of
transcatheter interventional therapy for congenital heart diseases, then develop
nursing strategies.
Methods: A total of 4096 patients who accepted transcatheter interventional
therapy between January 2011 and December 2015 were analyzed
retrospectively. Of these cases, 226 with severe pulmonary stenosis, 1389
with ventricular septal defect, 1170 with atrial septal defect, and 1133 with
patent ductus arteriosus. All personal information and perioperative period
data, including cardiac function, level of blood oxygen saturation, blood gas
analysis, operative time, puncture site, time for palinesthesia, time for ECG
monitoring, time for mechanical ventilation and complications were obtained
and classified according to risk stratification. Then, univariate and multivariate
logistic regression analyses were performed.
Results: The success rate for transcatheter interventional therapy is 98.7%.
Univariate logistic regression analysis identified age, weight, cardiac function,
level of blood oxygen saturation, pH, time of operation, vessel puncture,
time for palinesthesia, time for ECG monitoring, time for mechanical
ventilation as significant risk factors of complications (p<0.05). While in
multivariate logistic regression analysis, weight, time of operation, degree
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of cyanosis, diameter of defect, distance to aortic valve, pulmonary artery
hypertension are identified as significant risk factors of complications
(p<0.05). We, the nursing staff, should notice the unique risks of transcatheter
interventional therapy and develop early stage nursing management for these
perioperative risk factors.
Conclusions: Transcatheter interventional therapy is safe and effective. Key
point to assure a good postoperative recovery and to successful therapy is
that nursing staff should be aware of the risk factors of perioperative period
of transcatheter interventional therapy, the significant risk factors of
complications and the influences of operation and recovery, and plan an early
stage nursing intervention in advance.
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Purpose: In order to explore the surgical results at molecular basis in
individuals, to understand possible changes of the proteomic pattern after
surgical repair towards "Precision Medicine" in the postoperative
rehabilitation and the long term outcome obviously is of significance. We
designed the present study to compare the proteomic pattern in the pre- and
post-operative period in tetralogy of Fallot (TOF) and ventricular septal defect
(VSD) order to find the clinically important changes.
Methods: Differential protein analysis was performed in the plasma samples
of patients with TOF or VSD preoperatively (n=15 in each group), 6-month
postoperatively (n=15, in each group), and normal controls by using twodimensional electrophoresis and mass spectrometry. Altered proteins that
might be related to disease processes were further confirmed by enzymelinked immunosorbent assay (ELISA) in the samples from new group of
patients (n=26 in each group).
Results: In proteomic studies, a total of 473 protein spots in preoperative
patients and 515 in postoperative patients were detected. Significantly
(p<0.01 vs. control) downregulated (11 in preoperative and 15 in postoperative
group) and upregulated (14 in preoperative and 7 in postoperative group)

Initial Experience of a New ASD Closure Device in Hong Kong −
Cocoon Septal Occluder
GSH Cheung, AYY Cheong, AKY Chan
Department of Medicine & Therapeutics, Prince of Wales Hospital, Hong
Kong
Background: Percutaneous transcatheter closure with double disc occluder
is the preferred method for the majority of patients with secundum atrial
septal defect (ASD) currently. Despite high closure rate and few major
complications, the current device has been rarely associated with liftthreatening aortic erosions and severe allergic reactions due to nickel leakage
into blood stream. Compared to non-coated nickel containing occluders, the
important properties of Cocoon Septal Occluder (CSO) are the nanoplatinum
coating and its softness resulting predominantly from the removal of the
oxide of Nitinol during its preparation process.
Objectives: The aim of this study was to examine the initial experience and
results of usage of CSO in Chinese patients.
Methods: We conducted a retrospective review of consecutive 10 patients
had ASD closure by CSO from August 2015 to March 2016 in Hong Kong.
Results: Ten Chinese patients (7 female, 3 male) received CSO for ASD
closure with intra-cardiac echographic guidance, with median age 46.6 years
(range 26-59 years). Nine of them just had single defect, and one was
fenestrated ASD with three defects. All of the indication for closure was right
heart volume overload. All of them had right heart catheterization before
closure, and the shunt ratio before procedure was 2.78 (range 1.6-3.9 mmHg).
Mean ASD diameter was 14.3 mm (range 8-24 mm), while the mean device
diameter was 19.4 mm (range 12-30 mm). That fenestrated case received two
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protein spots were detected. Further validation of the chosen proteins by
ELASA in the new group of patients demonstrated that in VSD patients,
postoperative Complement Component C3c (45945.6±1553.1 vs. 39591.3
±1411.9 ng/ml, p<0.05) was partially and serum amyloid p-component (30.6
±0.7 vs. 29.0±0.3 ng/ml, p<0.05) was completely recovered from the lower
level preoperatively. In TOF patients, postoperative gelsolin (74115.3±13110.2
vs. 41897.4±2885.2 ng/ml, p<0.05) was partially and alpha-1-antitrypsin
(8672602.0±525882.2 vs. 4532717.8±718371.5 nIU/ml, p<0.01) was
completely recovered. In contrast, the elevated fibrinogen gamma chain level
in preoperative patients (575046.0±27460.6 ng/ml, p<0.01 vs. control)
became normal postoperatively (523043.1±18162.51 ng/ml, p=0.1 vs.
control).
Conclusions: We have for the first time, by using proteomic methods with
further validation, demonstrated that repair operations in CHD change the
protein profiles and correct preoperative abnormal protein levels in the plasma.
Owing to the fact that these proteins either function as acute phase proteins
(serum amyloid p-component), play a central role in the complement system
and contribute to innate immunity (complement component C3c), or play
importance role in coagulation (gelsolin and fibrinogen gamma chain), our
findings further demonstrate that intracardiac repair may restore the abnormal
protein functions related to immune system and coagulation profile in CHD
patients.

16 mm devices, while all other had one device only. All devices were
successfully implanted without need of change to different device size in all
patients. Echocardiographic examination immediately after the procedure
and at the one-month follow-up showed complete closure of the defect in all
patients. No any complication, or any adverse allergy reaction or mortality
was observed during the procedure or at short term follow-up, mean 4 months
(range 1-7 months).
Conclusion: This initial experience of CSO in Hong Kong indicated that
this device is a reasonable and safe choice for percutaneous transcatheter
closure of ASDs in Chinese patients. Moreover, CSO could also be used in
fenestrated ASD closure. Further studies with longer follow up period in a
larger patient size are necessary to show its efficacy and safety.
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Background: Majority of Transcatheter Aortic Valve Implantation (TAVI)
for treatment of severe aortic stenosis (AS) were performed via femoral artery
route with high success rate and low complication rate. Due to the presence
of severe diseased femoral or iliac arteries in some TAVI candidates,
alternative access routes are developed, including via subclavian or carotid
arteries, left ventricular apex, and ascending aortic (i.e. direct aortic approach).
In this study, we shared our initial experience and results of direct aortic
(DA) approach for TAVI in Prince of Wales Hospital (PWH).
Methods and Results: Among all 22 TAVI performed in PWH between
March 2015 and February 2016, three patients with symptomatic severe AS
underwent the procedures via DA approach, with mean age 80 years old
(range 77-82) and mean weight 51.3 kg (range 45-59.2). The mean STS score
was 9.56%, and all patients were considered high-risk surgical candidates in
the Heart Team meeting. The reason for direct aortic approach was all due to
the small caliber of both femoral arteries in two patients, and one patient had
severe descending aortic aneurysm. All procedures were performed under
general anesthesia with transesophageal echocardiographic guidance in the
hybrid operation theatre. Aortic valve area increased from 0.51 cm 2 (0.40.62 cm2) to 1.8 cm2 (1.4-2.3 cm2) with mean pressure gradient improved

Clinical Results of Catheter Based Percutaneous LAAO
Procedure in Patients with Non-valvular Atrial Fibrillation −
A Single Centre Experience
YW Cheng, YH Fong, MW Chu, CF Tsang, CK Kwok, NH Luk, SF Chui,
KC Chan, LK Chan, CY Wong, CL Fu, KY Lee, KC Ho, KT Chan, CS Chiang
Department of Medicine, Queen Elizabeth Hospital, Hong Kong
Background: In patient with non-valvular atrial fibrillation (AF), majority
of thrombus accumulation originates in the left atrial appendage (LAA). Longterm anticoagulant therapy has been the standard treatment. However, the
associated bleeding risk is significant in certain patient groups especially
elderly and those who experienced major bleeding events. Transcatheter based
occlusion of left atrial appendage has proved to be non-inferior to warfarin
in preventing stroke in non-valvular AF patients.
Objective: To evaluate clinical results of catheter based percutaneous LAAO
in patient with non-valvular AF performed at Queen Elizabeth Hospital.
Methods: A retrospective review of all patient undergoing catheter based
percutaneous LAAO procedure in Queen Elizabeth Hospital was performed.
Parameters for registry of LAA occluders listed in EHRA/EAPCI consensus
statement on LAA occlusion were collected and analyzed with SPSS 19.0.0.
Result: Since February 2013, percutaneous LAA occlusion was successfully
performed in 40 patients. All procedures were performed under general
anaesthesia (GA) and trans-esophageal echocardiography (TEE) guidance.
The mean age was 73.0 (± 7.64) years. The mean CHA2DS2-VASc score
was 4.15 while the mean HAS-BLED score was 2.88. Majority had permanent
AF and more than half of them (55%) had history of intracranial hemorrhage.
28 patient received Watchman TM device and 12 received Amplatzer TM
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from 64 mmHg (50-84 mmHg) to 9.5 mmHg (5.1-12.0 mmHg). No more
than moderate paravalvular leak was detected. There was no patient requiring
permanent pacemaker implantation, no stroke, and no conversion for full
sternotomy. One patient complicated with acute kidney injury at post TAVI
day two and required temporary hemodialysis for two days, and her kidney
function returned to her baseline afterwards. The 30-day mortality was 0%.
All three patients showed symptomatic improvement from NYHA class III
to class I.
Conclusion: From this case series, direct aortic approach for TAVI is found
to be feasible in small size Chinese patients with severe symptomatic aortic
stenosis if transfemoral approach for TAVI is contraindicated.

Cardiac Plug/Amulet TM device. The mean implant size was 28.1 mm. There
were 2 patients received paracentesis for pericardial effusion and another 2
was treated conservatively. Other complications included 2 minor bleeding
(wound hematoma and haematuria), 1 pneumothorax after GA and 1 acute
renal failure. There was no device embolization, peri-procedural cerebral
event nor death during hospital admission. On FU TEE, 12 patients had trivial
leakage 1-2 mm detected. Two cases with Watchman device had leakage
>3 mm while less than 5 mm. No device thrombus was detected. 30 days
mortality and 1 year stroke rate was 0%.
Conclusion: Percutaneous LAA occlusion is a reasonable alternative to
selected patient for stroke prevention in patients with non-valvular AF with
increased stroke and bleeding risk/cannot tolerate oral anticoagulant. The
success rate was comparable to the standard in literature.
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Introduction: In recent years, Transcatheter Aortic Valve Implantation (TAVI)
has been developed as alternative treatment for patients with symptomatic
severe aortic stenosis who are deemed to be of high risks for conventional
surgical aortic valve replacement (SAVR). Due to complex anatomy, patients
with severe bicuspid aortic valve stenosis were excluded from randomized
TAVI trials and the data of these patients undergoing TAVI were limited. The
aim of this study was to evaluate the efficacy, safety and short-term clinical
outcomes of patients with severe bicuspid aortic valve stenosis undergoing
TAVI.
Method: Hospital records of all patients who had TAVI procedure from
December 2010 to February 2016 in a local regional hospital were reviewed.
The baseline characteristics, imaging findings (CT and Echocardiogram),
procedural outcome and 30-day clinical outcome were analyzed.
Results: A total of 67 patients received TAVI procedure during the study
period. Fifty-eight patients had tricuspid aortic valve stenosis, 8 patients had
bicuspid aortic valve stenosis and one patient had severe aortic regurgitation.
Among those who had bicuspid aortic valve stenosis, the mean age was
77.9 (±5.2), with 2 of them (25%) are female. The mean LVEF was 45.6%
(±12.5%). All procedures were done under general anaesthesia in our cardiac
catheterization laboratory with 100% procedural success. Aortic valve area

Percutaneous Left Atrial Appendage Occlusion under Monitored
Anesthetic Care: Single Centre One-year Experience in Hong
Kong
GSH Cheung,1 AKY Chan,1 AYY Cheong,1 KKH Kam,1 APW Lee,1 S Au,2 S Chan2
Department of Medicine & Therapeutics; 2Department of Anaesthesiology,
Prince of Wales Hospital, Hong Kong

1

Background: Percutaneous left atrial appendage occlusion (LAAO) for stroke
prevention in patients with atrial fibrillation (AF) is usually performed under
general anaesthesia in many centres due to prolonged intubation of transesophageal echocardiographic (TEE) probe. With the support from the
anaesthetists, our percutaneous LAA occlusion pragram was run regularly
under the monitored anaesthetic care (MAC) without the need of endotracheal
intubation.
Objective: The aim of this study was to share our experience and to evaluate
the performance of the LAAO program.
Methods: In this study, we shared our experience and evaluated the
performance of the LAAO program between January and December 2015 in
Prince of Wales Hospital in Hong Kong.
Results: 44 patients (28 males and 16 females) received percutaneous LAAO
under MAC session. The average age was 73.9 years old (range 60-84), and
the mean CHA2DS2-VASc and HAS-BLED scores were 4.1 and 3.1
respectively. Twenty-five (57%) Watchman and 19 patients (43%) Amulet
LAAO devices were implanted in all patients with mean procedural of 66.9
minutes and fluoroscopic time of 15.3 minutes. There were two (4.5%) minor
complications as vascular access site hematoma, which were managed
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improved from 0.64 (±0.20) to 1.98 (±0.54). Two patients (25%) had mild to
moderate para-valvular leakage after procedure and only 1 patient (12.5%)
had mild to moderate para-valvular leakage on subsequent follow-up
echocardiogram. All patients reported symptomatic improvement on
subsequent follow-up visit with improvement of NYHA class 1.0. One of
these 8 patients had permanent pacemaker implanted (12.5%). The 30 days
mortality was 0%.
Conclusions: In patients with severe bicuspid aortic valve stenosis who are
deemed high risks of SAVR, TAVI is feasible and safe option with good shortterm outcome.

conservatively. There were two (4.5%) major complications as cardiac
tamponade requiring urgent open heart repair, and both patients discharged
home after 10 days and 30 days hospitalization. After excluding those two
patients, the average length of hospital stay was 3.6 days (range 2-7 days).
There was no any device embolization, stroke, systemic embolism, air
embolism, aspiration pneumonia, or procedural related death.
Conclusion: Percutaneous LAAO under MAC is feasible and safe. Major
complication is uncommon, and could be managed promptly even under MAC.
LAAO under MAC might be a good alterative in patients for AF stroke
prophylaxis.
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Transcatheter Structural Heart Intervention: One-year
Experience in a Tertiary Hospital in Hong Kong in 2015
GSH Cheung, AKY Chan, AYY Cheong, KKH Kam, APW Lee, EB Wu,
JYS Chan
Department of Medicine & Therapeutics, Prince of Wales Hospital, Hong
Kong
Background: The development of percutaneous approaches for structural
heart diseases has seen tremendous advances over the past decade. Increased
recognition and understanding of those disease processes and related treatment
options prompt to establishment of structural heart team in different overseas
cardiac centres. We summarized and evaluated the one-year experience and
results of transcatheter structural heart intervention in one tertiary hospital
in Hong Kong.
Purpose: To provide better service to patients with structural heart diseases
through a team approach.
Methods: A retrospectively review of all patients underwent transcatheter
structural heart intervention between January to December 2015 in Prince of
Wales Hospital was performed. Patients' demographics, clinical
characteristics, operative procedures, postoperative complications and
outcome were recorded and analyzed. Types of complication were classified
as major and minor, with reference to the definition from VARC-2 consensus
document.
Results: In 2015, there were 107 procedures of percutaneous transcatheter
structural heart intervention performed. The average age was 66.3 years old
(range 22-88), male and female patients were similar in proportion (48% vs.
52%). Among them, there were 47 cases (43.9%) of left atrial appendage
occlusion, 18 cases (16.8%) of transcatheter aortic valve implantation,
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18 cases (16.8%) of atrial septal defect closure, 11 cases (10.3%) of
percutaneous transcatheter mitral commissurotomy, 3 cases (2.8%) of patent
foreman ovale closure; and the remaining 10 cases (9.4%) included
percutaneous mitral valve repair by MitraClip, patent ductus arteriosus
closure, ventricular septal defect closure, balloon aortic valvuloplasty,
pulmonary arterio-venous malformation occlusion, bilateral branch pulmonary
artery stenting, coronary arterial fistula occlusion, paravalvular leakage
closure. The procedural successful rate was 97.2%; Major and minor
complication rates were 4.6% and 14.0% respectively. There was no
procedural related death. The 30-day mortality was 1.9% (n=2), and the causes
of death were pneumonia and septicemia. More than half of the procedures
were transesophageal echocardiographic guidance (n=65, 60.7%), while 32
(29.9%) and 10 (9.3%) were under intracardiac echocardiographic and
fluoroscopic guidance.
Conclusion: The percutaneous transcatheter intervention for structural heart
disease includes a wide spectrum of cardiac problems. The team approach in
this rapidly developed field of cardiology could provide better clinical care
in term of safe, effective with high success rate.
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Bystander Cardiopulmonary Resuscitation Awareness and
Automated External Defibrillator Distribution Survey in Hong
Kong
K Chan,1 NY Chan2
Department of Cardiology, Ruttonjee and Tang Shiu Kin Hospitals;
2
Department of Cardiology, Princess Margaret Hospital, Hong Kong

1

Purpose: We aim to study the knowledge of general public in bystander
cardiopulmonary resuscitation (CPR)/defibrillation and the distribution of
community automatic external defibrillators (AEDs) in Hong Kong.
Method: A telephone survey was conducted to assess the public awareness
of the significance of bystander CPR and defibrillation. Respondents were
questioned regarding their knowledge about bystander CPR and AEDs. The
AED survey was conducted via written questionnaires sent to four major
local AEDs providers. The total number and the geographical distribution of
community AEDs were assessed.
Result: A total of 524 successful telephone interviews were conducted. Only
23% and 4.6% of the respondents had been trained in CPR and AEDs use
respectively. Among the trained respondents, only 54% and 15% were willing
to provide by-stander CPR and defibrillation respectively, in case of witnessed
OHCA. This low motivation to offer bystander CPR/defibrillation was
attributable to forgetfulness about CPR technique, lack of training/confidence,
expiry of certificate, and reluctance to help strangers. There were 5084 AEDs
installed in the community by April 2014. The community AEDs were
installed in government offices (N=1423; 28%), non-government
organizations (N=905; 18%), commercial buildings (N=649; 12.8%), schools
(N=537; 10.6%), sports stadiums (N=401; 8%), housing estates (N=379;

Sudden Arrhythmia Death Syndromes in Young Victims of
Sudden Cardiac Death in Hong Kong Identified by Clinical or
Molecular Autopsy of Victims and Clinical Evaluation of Their
First Degree Relatives (SADS-HK Study)
NS Mok,1 C Mak,3 HC Shum,2 C Siu,3 YK Lo,1 CL Lau,1 CB Tso,2 WM Poon,2
NC Fong,4 C Chong,3 S Cheung,3 D Ching,3 H Lee,3 PT Tsui,1 KC Lee3
1
Department of Medicine & Geriatrics, Princess Margaret Hospital (PMH);
2
Forensic Pathology Service, Department of Health; 3Department of Pathology,
PMH; 4Department of Paediatrics, PMH, Hong Kong
Objectives: Sudden cardiac death (SCD) in young people is not uncommonly
caused by inheritable arrhythmogenic disorders known as Sudden Arrhythmia
Death Syndromes (SADS) in overseas studies. We sought to determine the
prevalence and types of SADS underlying SCD among local young victims
through clinical and molecular autopsy of SCD victims and clinical and
genetic evaluation of their first degree relatives (FDR).
Methods: This is a prospective study. Young SCD victims (age 5-40 years)
with either an inheritable arrhythmogenic cardiomyopathy or no structural
heart disease identified on autopsy and a negative toxicology screening and
their FDR will be recruited into study. Molecular autopsy of SCD victims is
done by Next Generation Sequencing (NGS) to identify pathogenic mutation
in 35 SADS-related genes. All recruited FDR will undergo clinical evaluation
for SADS. Mutation-specific family screening will be performed if pathogenic
mutation is found in probands.
Results: As of March 2016 seventeen SCD victims (M:F 13:4, mean age
26.5±7.4 years) and 46 FDR (M:F 24:22, mean age 41.0±16.6 years) were
recruited into the study after 18 months of recruitment. Clinical autopsy found
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7.5%), Mass Transit Railway stations (N=295; 5.8%), shopping malls (N=255;
5%), universities/colleges (N=162; 3.2%), theme parks (N=55; 1.1%), airport
(N=12; 0.2%), piers (N=7; 0.14%), and racecourses (N=4; 0.08%). Only
approximately 20% of AEDs (N=1029) were installed in publicly accessible
areas, which translated into 14 publicly accessible AEDs per 100,000
population.
Conclusion: The public CPR/AEDs training rate and motivation to offer
bystander CPR/defibrillation was low. The community AEDs installation
rate and public accessibility was low. A community-wide program to improve
bystander CPR/AED training rate and more strategic installation of
community AEDs is required to improve bystander CPR/defibrillation rate.

arrhythmogenic right ventricular cardiomyopathy (ARVC) in 2 and
structurally normal heart in 15 SCD victims. Molecular autopsy was
completed in 14 SCD victims. Pathogenic or likely pathogenic mutations in
DSP, DSC2, AKAP9, MYBPC3 and RYR2 genes, as defined by in silico
analysis, were found in 6 SCD victims. These mutations were implicated in
ARVC, ARVC, long QT syndrome, hypertrophic cardiomyopathy and
catecholaminergic polymorphic VT (CPVT) respectively. 11 FDR were found
to be asymptomatic carriers of known mutation of the probands. Among them
only 1 with DSP mutation demonstrated phenotype of ARVC while the rest
of them could not be identified by clinical evaluation due to absence of clinical
phenotype.
Conclusions: This is the first local genetic and clinical study to identify
SADS in young SCD victims and their FDR in Hong Kong. Preliminary data
suggest that SADS are not uncommonly implicated in SCD among young
victims. Molecular autopsy using NGS is able to characterize the pathogenic
genetic defects in SADS victims and facilitate the identification of mutation
carriers in their FDR which allows early preventive treatment to be initiated
to reduce their risk of SCD.

April 2016

34

HK COLLEGE OF CARDIOLOGY, TWENTY-FOURTH ANNUAL SCIENTIFIC CONGRESS
ABSTRACTS
Abstracts for Free Paper Session:
CARDIAC ARRHYTHMIA
A Comparison of Mortality Rate with Cryoballoon and
Radiofrequency Ablation for Atrial Fibrillation
Z Lu, YH Zhuang, HX Wu
The Second People's Hospital of Shenzhen, China
Purpose: Radiofrequency ablation is the current standard method for atrial
fibrillation, while cryoballoon ablation is the emerging alternative. We try
to evaluate the influence of cryoballoon and radiofrequency ablation on
mortality.
Methods: In search of peer-reviewed articles from Medline, Embase and
Cochrane database. We conducted the search from 2010 to 2016. Two
independent reviewers reviewed the titles, abstracts and collected the data
from studies that met the inclusion criteria. Conflicts between reviewers were
resolved by consensus. Heterogeneity was analyzed with I². Pooled hazard
ratio (HR) as the effect size and 95% confidence interval were used to estimate
the association of cryoballoon and radiofrequency ablation in mortality by
randomized effect model with M-H method.
Results: A total of 5 studies were included which fitted the inclusion criteria.
In comparison with radiofrequency ablation group, the cryoballoon ablation
group showed a pooled HR 0.92 with 95%CI 0.78-1.38, P=0.58.
Conclusion: Cryoballoon ablation is not associated with increased risk of
mortality.

Excess Risk of Incident Atrial Fibrillation and Activated Vascular Repair
Cascades among High-Risk Cardiac Patients with Selenium Deficiency
KH Yiu, KK Lau, SW Li, CP Lau, CW Siu, HF Tse
Division of Cardiology, Department of Medicine, Queen Mary Hospital,
Hong Kong

Conclusions: Selenium deficiency is associated with an excess risk of incident
AF, as well as altered indicators of vascular repair activation which may
provide an explanatory pathophysiological mechanism for the clinical events.

Background: Selenium deficiency was associated with heart failure and
accelerated atherosclerosis, but its role in atrial fibrillation (AF) was unknown.
Methods: We prospectively investigated 558 high-risk patients with prior
coronary disease, ischemic stroke and/or type 2 diabetes in a clinical cohort.
CD34+/KDR+ and CD133+/KDR+ circulating endothelial progenitor cells
(EPC) were determined by flow cytometry. New-onset AF was ascertained
from the computerized medical record system over a 5-year follow-up period.
Selenium deficiency was defined as <22 mcg/day (from prior pilot study) as
determined from a validated food frequency questionnaire.
Results: Over 63±11 months, 2% patients (9/558) developed new-onset AF.
Selenium deficiency (prevalence 16%) was associated with increased risk of
new-onset AF (chi-square P=0.001). C-statistic for prediction of AF by
selenium deficiency was 0.70 (P=0.040). Kaplan-Meier analysis showed that
selenium deficiency was associated with reduced AF event-free period (logrank 17.7, P<0.001). Adjusted for potential confounders (age, gender,
smoking, history of coronary disease/stroke, body-mass index, systolic/
diastolic blood pressure, pulse rate, serum LDL, HDL and triglycerides,
HbA1c, statin/aspirin use), selenium deficiency remained independently
associated with increased risk of AF (HR 10.5 95%CI 1.1-99.0, P=0.041).
Furthermore, selenium deficiency was associated with reduced CD34+/KDR+
EPC and raised CD133+/KDR+ EPC.
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Variable Clinical Presentations of Left Atrial Myxoma in
Malaysia: A Case Series
PX Kuan,1 HS Ling,2 K Andrew,3 AYY Fong1,3
Clinical Research Centre, Sarawak General Hospital; 2Department of
Medicine, Sarawak General Hospital; 3Department of Cardiology, Sarawak
Heart Centre, Malaysia

1

Introduction and Purpose: Cardiac myxoma is the most common primary
tumour of the heart; often missed due to non-specific symptoms. It may lead
to disastrous outcome if it is not treated in a symptomatic patient.
Transthoracic echocardiogram (TTE) is the usual imaging modality for
establishing the diagnosis.
Methods: We reviewed the different types of presentations and outcomes of
patients presented to Sarawak General Hospital, Malaysia with myxoma in
2015.
Results: Case One: A 67-year-old gentleman, initially treated as bronchial
asthma, referred to our centre for worsening shortness of breath despite being
treated for one week. Chest X-ray (CXR) was unremarkable. Further workup with TTE showed left atrial mass suggestive of myxoma measuring
4.3 cm x 3.8 cm. Case Two: A 38-year-old lady, with history of ischemic
stroke, presented with sudden unilateral limb weakness and fever. No
significant neurological deficit but peripheral vasculitic lesions were noted.
She was initially investigated for infective endocarditis with embolic event.
However, repeated TTE in our centre showed left atrial mass suggestive of
myxoma, measuring 2.1 cm x 2.7 cm. Case Three: A 73-year-old previously
healthy woman, presented with worsening reduced effort tolerance over the
past one month. Examination was suggestive of left heart failure; consistent

Targeted Delivery of Hydrogen Sulfide by Ultrasound Mediated
Microbubble Destruction Alleviates Myocardial Ischemiareperfusion Injury
GB Chen, J Liu, L Yang, JP Bin, JF Wu
Department of Cardiology, Nanfang Hospital, Southern Medical University,
China

with CXR findings. Initial TTE showed atrial mass (1.4 cm x 7.2 cm) causing
mitral valve obstruction and pulmonary hypertension.
Discussion/Conclusion: The diagnosis of atrial myxoma can be ambiguous
and may be easily missed, especially when the different clinical presentations
are suggestive of other diagnoses. TTE is investigation of choice for
diagnosing myxoma in symptomatic patients. Early surgical intervention is
warranted for better outcome. Our review showed all tumour excisions were
successful and histopathological examinations confirmed myxoma. Although
myxoma is histopathologically benign, they can lead to serious complications
e.g. embolism and intracardiac obstruction.

significant hemodynamic changes were observed during ultrasound mediated
hs-MB destruction.
Conclusions: Delivery of H 2 S by ultrasound mediated microbubble
destruction limits the extent of myocardial ischemia-reperfusion injury. This
may provide a noninvasive strategy for targeted delivery of a therapeutic gas
to protect myocardial injury from ischemia-reperfusion, avoiding systemic
side effects.

Background: Hydrogen sulfide (H2S) is an attractive agent for myocardial
ischemia-reperfusion injury, however, systemic delivery of H2S may cause
unwanted side effects. Ultrasound mediated microbubble destruction has
become a promising tool for organ specific delivery of bioactive substance.
We hypothesized that intravenous administration of microbubbles
encapsulating H2S gas combined with ultrasound exposure permit local release
of H2S and alleviates myocardial ischemic-reperfusion injury.
Methods: We developed and characterized microbubbles carrying hydrogen
sulfide (hs-MB) with different H2S/C3F8 ratios (4/0, 3/1, 2/2, 1/3, 0/4) and
determined the optimal ratio. Release of H2S trigger by ultrasound was
investigated in vitro. In a rodent model of myocardial ischemia-reperfusion
injury, hs-MB were administered intravenously with ultrasound applied over
the heart. Infarct size was determined by evans blue and TTC staining. Left
ventricular structure and function was assessed by echocardiography.
Results: The H2S/C3F8 ratio of 2/2 was found to be an optimal ratio to prepare
stable hs-MB with higher H2S loading capability. The concentration of the
hs-MB decreased while the dissolved H 2S increased significantly after
exposure to ultrasound. Ultrasound targeted hs-MB destruction limited the
extent of myocardial injury and preserved left ventricular function. No
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Ultrasonographic Study of Cardiac Function in Larger Twin of
Selective Intrauterine Growth Restricted
X Zhang, HJ Ba, YS Lin, XD Li, HS Wang
The First Affiliated Hospital, Sun Yat-sen University, China
Objective: To evaluate cardiac function in larger twin of selective intrauterine
growth restricted (sIUGR) using 2D and color Doppler ultrasonography.
Methods: Thirty-five sIUGR pregnancies and thirty-five normal Single
pregnancies with same gestational week were enrolled, Cardiac structure
and Doppler patterns of the Atrioventricular valve, Tricuspid annulus systolic
displacement (TAPSE), Fractional shortening of left ventricle short axis (FS)
and myocardial performance index (Tei index) of pulse Doppler were assessed.
Results: Cardiothoracic ratio, Ventricular wall thickness, regurgitation of
Atrioventricular valve, Isovolumetric relaxation time of left ventricle (LVIRT), Tei index of both Ventricle in larger twin of sIUGR (Tei index of left
ventricle: 0.45±0.07 vs 0.34±0.03, Tei index of right ventricle: 0.45±0.06 vs
0.35±0.03) were significantly higher than that in normal fetus (P<0.05).
TAPSE, FS and ejection time of left ventricle and right ventricle (LV-ET,
RV-ET) were no significant difference between two groups (P>0.05).
Conclusion: The diastolic function in larger twin of sIUGR were declined
obviously, but the systolic function were reserved at that time. Tei index of
pulse Doppler were helpful to clinical decision.

Papillary Fibroelastoma of the Mitral Valve − Case Report
L Wang, L Li
Department of Ultrasound, Union Hospital, Hong Kong

Clinical Presentation: A 52-year-old man presented at our hospital with a
complaint of redness and swelling of body joints. These symptoms appeared
out for over 16 years, and he was diagnosed with arthrolithiasis at local
hospital. He transferred to our hospital for further management because the
symptoms became more severe nearly for one month. There was primary
hypertension history for 15 years and diabetes for 17 years.
Physical Examination: On physical examination, his pulse rate and blood
pressure were all in the normal range. Nonspecific murmur was heard.
Electrocardiogram and Chest X-ray showed nonspecific changes.
Imaging Findings: Transthoracic echocardiography (TTE) and
transesophageal echocardiography (TEE) showed a small strong echo mass
(with approximate dimensions of 1.0 cm x 0.8 cm) adhere to anterior mitral
valve leaflet (Area A3), the root of the lesions was connected to left atrial
side of the valve. The mass presented smooth partial surface and irregularly
form, it can change the shape and activity with the cardiac cycle. Color
Doppler flow imaging showed that there was no blood flow signal in the
mass. Contrast enhancement ultrasound (CEUS) demonstrated smooth
opacification of the cavity with detection of contrast microbubbles in all
four chambers. There was no microbubble in the mass. The conclusion was
that there was a solid mass in the anterior mitral valve leaflet, which was
considered to be neoplasm, thrombus or tumour.
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Surgery Findings and Pathogenesis: At surgery, a neoplasm with fiber
basement was found in the edge of anterior mitral valve leaflet (dimensions
of 1 cm x 1 cm). There was filament all over the peripheral. The mass was
excised with removal of the base in the anterior mitral valve leaflet and the
valve function was not affected. Pathological examination demonstrated it
was papillary fibroelastoma of the mitral valve.
Summary and Discussion Points: 1) Papillary fibroelastoma often originated
from the valvular endocardium, and the final treatment is surgical excision;
2) TTE and TEE have advantages in accurately diagnosis of cardiac papillary
fibroelastoma; 3) Echocardiography results are highly consistent with what
was revealed in surgery.
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Echocardiographic Characteristics of Sinus of Valsalva
Aneurysm Extending into Left Ventricle
WJ Zhang, MX Xie, XF Wang, YL Yang
Department of Ultrasonography, Union Hospital, Tongji Medical College,
Huazhong University of Science and Technology, China

and prolapse of both aortic valve and annulus observed in every case, resulting
in a severe aortic regurgitation. Obstructions of the LVOT due to the spaceoccupying effect were also found.
Conclusions: The SVA extending into LV has distinguished echocardiographic
characteristics. Either conventional or live 3D echocardiography could diagnose
the disease and cardiovascular complications accurately.

Objective: To investigate image features of sinus of Valsalva aneurysm
(SVA) extending into left ventricle (LV) by echocardiography.
Methods: Echocardiographic features of 5 patients treated by surgery at our
hospital from July 1995 to September 2015 were reviewed retrospectively
and compared with surgical findings, 4 of them combined diagnosed by
conventional and 3D echocardiography before surgery.
Results: The origin, extending position, rupture status, complications of the
SVAs and associated cardiovascular lesions determined by echocardiography
were entirely consistent with surgical findings in all cases, with the exception
of one failed diagnosis of hypoplasty of an adjacent aortic cusp. Similar to
what was observed with common patterns, the aneurysm extending into LV
also presented a thin-walled saccular lesion arising from the aortic root in
continuation with the aortic annulus, with significant morphological changes
and movement in echocardiographic images. Some unique characteristics
were observed simultaneously: 1) very low origin of the saccular lesion arising
between the sinus base and the aortic annulus; 2) the aneurysm going back
and forth between the aortic root and the left ventricular outflow tract (LVOT)
in 4 cases with an intact interventricular septum, and between the LV and
the right ventricle through the septal defect in another case complicated by a
huge ventricular septal defect (VSD); 3) diastolic shunt into the LV when
ruptured; 4) compression and displacement of the adjacent aortic annulus
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Robotic Cardiac Surgery in Hong Kong
MKH Wong, DTL Chan, TWK Au
Division of Cardiothoracic Surgery, Queen Mary Hospital, Hong Kong
Traditionally, cardiac surgery is performed through median sternotomy
approach due to the requirements of cardiopulmonary bypass and complex
surgical procedures. Recent advances in techniques and instruments have
allowed less invasive approaches to become more available. The Robotic
assisted cardiac surgery programme started in Hong Kong in 2014. This study
aims to compare Robotic assisted cardiac surgery to other minimally invasive
approaches. From 2007 to 2015, a total of 222 patients had minimally-invasive
approach cardiac surgery performed. These approaches include hemisternotomy, para-sternotomy, thoracotomy, videoscopic assisted
minithoracotomy and robotic assisted minithoracotomy approach. There were
8 patients who underwent robotic-assisted minithoracotomy cardiac surgery.
Seven of them had mitral valve repair and 1 had atrial septal defect repair.
Post-operative echocardiogram showed no to trivial mitral regurgitation in
all 8 patients. There was no in-hospital mortality. One patient required reexploration for hemostasis. There were no significant difference in preoperative comorbidity, operative time, cardiopulmonary bypass time and postoperative complication rate compare to the other approaches. Robotic cardiac
surgery is a safe and effective minimally invasive approach in cardiac surgery.
It has potential benefits over other minimally invasive approaches, such as
superior 3D vision, less wound pain, the ability to perform more complicated
and delicate intra-cardiac procedure, etc. With continuous advances in this
technology, usage of the Robotic assist approach is expected to grow in the
future.

'Valve in valve' Aortic Valve Replacement with Sutureless
Perceval S Valve − A Third Treatment Option besides Surgical
Reoperation and Transcatheter Aortic Valve Implantation
MKH Wong, DTL Chan, TWK Au
Division of Cardiothoracic Surgery, Queen Mary Hospital, Hong Kong

62 minutes and cross clamp time was 45 minutes. Post-operative course was
uneventful and TTE on post-operative day 7 showed no paravalvular leak
and functioning AVR. She showed no symptoms of heart failure at 6 months
follow up. In this report, we demonstrate the feasibility of Sutureless Perceval
S valve implantation as a third treatment option in patients considered high
risk in both open surgery and TAVI.

Stentless valves such as St. Jude Toronto Stentless Porcine Valve (Toronto
SPV) provides hemodynamic advantages. However, valve failure due to leaflet
tear is common and many patients require re-intervention. Traditionally, these
patients have been treated via either aortic root replacement, or recently 'valve
in valve' transcatheter aortic valve implantation (TAVI). Sutureless Perceval
S valve bioprosthesis uses a sutureless technique that resembles TAVI valve
during open surgery. Thus, it can reduce cardiopulmonary bypass and cross
clamp time compared to traditional surgical valve replacement. In addition,
it can reduce the complications related to TAVI especially in patients with
unfavorable anatomy, e.g. low coronary ostia. We present the first case of
Sutureless Perceval S valve implantation in a 79-year-old lady with a failed
St. Jude Toronto SPV as 'valve in valve' implantation in Hong Kong. She
presented 13 years ago with symptomatic aortic stenosis (AS). Open AVR
was performed with Toronto SPV at the time. She was well until recent increase
in shortness of breath. Transthoracic echocardiogram (TTE) showed severe
aortic regurgitation with prolapsed right coronary cusp. CT scan of the aorta
showed a calcified aortic root with low lying coronary ostia. She was deemed
high risk for root replacement surgery and TAVI. We performed open redo
AVR for her with Sutureless Perceval S Valve in order to minimise the surgical
risk and decrease cardiopulmonary bypass (CPB) time. Total CPB time was
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Intra-operative Transit Time Flow Measurement for Coronary
Artery Bypass Grafting: A Prospective Computed Tomography
Angiography-controlled Study
KF Lee, OJ Lee, N Yam, BA Rocha, D Chan, KL Ho, WK Au
Department of Cardiothoracic Surgery, Queen Mary Hospital, University of
Hong Kong, Hong Kong
Purpose: Early graft failure is associated with poor clinical outcome in
coronary artery bypass grafting (CABG) patient and it is usually due to
technical factors which may be avoidable if recognized intra-operatively.
This has led to the development of intra-operative graft quality assessment
tools and the recommendation of routine graft flow assessment in the latest
international guideline. Among all the available assessment tools, transit time
flow measurement (TTFM) is most commonly used. It is convenient, noninvasive and objective. Several studies had demonstrated its predictive value
to early graft failure and major adverse cardiac events (MACE). However,
evidence on its usefulness and correlation to post-operative angiographic
findings is limited. With the advance of multi-slice high resolution computed
tomography (CT) and its increasing availability, CT coronary angiogram is
often regarded as the first line screening tool for suspected myocardial
ischemia. We therefore aim to evaluate the relationship of TTFM values and
post-op CT angiographic findings.
Methods: Between December 2014 and October 2015, TTFM were performed
in 59 CABG patients. Forty of them had post-op CT coronary angiogram
after a mean follow-up period of 26.7±3.8weeks. Baseline characteristics,
peri-operative details and follow-up data including CT coronary angiogram
findings were prospectively collected. TTFM was done using Medistim
VeriQTM System. Variables including pulsatility index (PI) and diastolic flow
(DF) were recorded.

Endothelial NOS Enhancer AVE3085 Protects Endothelial
Function from the Injury Induced by Homocysteine in Human
Internal Mammary Artery and Clinical Implications
HT Hou,1,2 J Wang,1 ZQ Wang,1 TN Chen,1 XC Liu,1 Q Yang,1,3 GW He1,2,4
Department of Cardiovascular Surgery & Center for Basic Medical Research,
TEDA International Cardiovascular Hospital, Chinese Academy of Medical
Sciences, China; 2The Affiliated Hospital of Hangzhou Normal University
& Zhejiang University, China; 3The Chinese University of Hong Kong, Hong
Kong; 4Department of Surgery, Oregon Health and Science University, USA
1

Results: A total of 117 grafts were performed which comprised of 74 long
saphenous veins (SVG), 36 left internal mammary arteries (LIMA) and
7 radial arteries (RA). In view of the scarcity of radial artery grafts, they were
excluded in further analysis. The early CT angiographic graft patency was
88.6% (94 out of 106). The mean PI of the CT angiographically patent grafts
is significantly lower than that of the stenotic grafts (3.2±1.9 vs 5.1±5.1,
p=0.02). However, there is no significant difference of the mean DF among
two groups (60.1±13.3) vs 52.7±17.8, p=0.096).
Conclusions: A high PI in TTFM seems to be associated with early graft
failure. It may serve as a useful tool to identify defective graft intra-operatively
and suggest for graft revision.

expression of eNOS at mRNA levels (P<0.05). Adding AVE3085 to Hcy
significantly increased the eNOS protein (P<0.05) ad slightly decreased the
mRNA level.
Conclusions: Hcy caused endothelial dysfunction through the modulation
of NO production associated with a downregulation of eNOS in human IMA.
AVE3085 prevents endothelial dysfunction attributed to upregulation of eNOS
expression. These findings provide new insights into the protection of the
endothelium of the coronary artery bypass grafting conduit and to improve
the long-term patency of the grafts.

Purpose: Homocysteine (Hcy) is a sulfur-containing amino acid formed
during the metabolism of methionine. Hcy is an independent and risk factor
for endothelial dysfunction in cardiovascular diseases and atherosclerosis in
the general population. We hypothesized that the eNOS transcription enhancer
AVE3085 might improve the endothelial function altered by Hcy in the human
internal mammary artery (IMA).
Methods: Cumulative concentration-relaxation curves to acetylcholine (-10
to -4.5 log mol/L) were established in IMA (n=64) from 16 patients undergoing
coronary artery bypass grafting in precontraction induced by U46619 (-8 log
mol/L) in the absence or presence of Hcy (100 µmol/L) with/without
AVE3085 (30 µmol/L) in vitro. Reverse transcription-polymerase chain
reaction (RT-PCR) and enzyme-linked immunosorbent assay (ELISA) were
used to quantify the mRNA and protein levels of eNOS.
Results: Maximal relaxation induced by acetylcholine was significantly
attenuated by Hcy in human IMA. Co-incubation with AVE3085 protected
endothelium from the impairment of Hcy. Exposure to Hcy for 24 h
downregulated eNOS protein expression (P<0.05) whereas it upregulated the
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Association of Blood Pressure Level with Nonalcoholic Fatty
Liver Disease in Non-hypertensive Population: Normal is not the
New Normal
LY Qian, YH Ding, J Pang, XD Che, H Zou, DS Huang
Zhejiang Provincial People's Hospital, China
Background and Aim: Some literatures have reported the relationship
between NAFLD and hypertension, but there is no article describes the
characteristic of NAFLD in non-hypertensive individuals. This study aimed
to determine the strength of the association between NAFLD with normal BP
in non-hypertensive individuals.
Method: A cross-sectional study was conducted among patients who came
to the sixth Affiliated Hospital of Wenzhou Medical University from October
2007 to December 2011.
Results: Of the 24200 enrolled subjects, 5305 filled the diagnostic criteria
for NAFLD (21.9%; 4803 males and 502 females). Non-hypertension was
identified in 17403 (71.9%; 8179 males and 9224 females). The PR% of
NAFLD for the SBP in quartile 1, quartile 2, quartile 3, and quartile 4 was
10.83, 12.55, 20.38, and 19.97. SBP, DBP, sex, age, ALB, GPT, GOT, FPG,
UA, TG, HDL-C and LDL-C are closely associated with the risk for NAFLD.
SBP (OR: 1.092, 95%CI: 1.030-1.158; P<0.05) and DBP (OR: 1.157, 95%CI:
1.094-1.223; P<0.05) were found to be independent risk factors for NAFLD.
Conclusions: BP is significantly associated with NAFLD in non-hypertensive
individuals; SBP and DBP are found to be independent risk factors for
NAFLD.

The Prevalence of Impaired Fasting Blood Glucose in Individuals
with Optimal, Normal and High Normal Blood Pressure in Macau
SAR
HM Cheung,1,2 L Ke,1 XH Feng,1 JZ Feng1
1
Macau Hypertension Alliances, Macau; 2Department of Medicine and
Geriatrics, Kwong Wah Hospital, Hong Kong
Purpose: To investigate the prevalence of impaired fasting blood glucose in
individuals with high normal blood pressure among residents in Macau SAR.
Methods: A territory-wide cross-sectional population-based survey on the
risk factors of hypertension was conducted in Macau SAR, 2012. Household
based random sampling design was used. Residents aged 18 years or above
of each household were recruited. Blood pressure was measured twice
individually and blood samples were collected and analyzed at the Kiang
Wu Hospital, Macau. Taking reference to the 2013 ESH/ESC Guidelines for
the management of arterial hypertension, optimal blood pressure (OBP) was
defined as a systolic blood pressure of <120 mmHg and a diastolic blood
pressure of <80 mmHg. Normal blood pressure (NBP) was defined as a SBP
of 120-129 mmHg and/or a DBP of 80-84 mmHg and high normal blood
pressure (HNBP) as a SBP of 130-139 mmHg and/or a DBP of 85-89 mmHg.
Impaired fasting blood glucose was defined as a fasting blood glucose level
of 5.6-6.9 mmol/L according to the American Diabetes Association.
Participants having a history of diabetes mellitus or hypertension or found to
have hypertension or having a fasting blood glucose level of 7.0 mmol/L or
above were excluded. Post-stratification adjustment was performed to adjust
for age, sex, non-responding households and non-responding residents.
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Results: Among a total of 1410 participants, 36.5% were excluded because
they were either found to have hypertension or diabetes mellitus. Three
hundred and forty-nine of the remaining 895 participants consented to blood
taking (212, 93 and 44 in the OBP, NBP and HNBP groups respectively).
15.6%, 30.5% and 28.4% of the participants were found to have impaired
fasting blood glucose in the OBP, NBP and HNBP groups respectively. Chisquare tests revealed that sex (being male) (P<0.001), drinking (P=0.001),
BMI 23 or above (P<0.001), age 50 years or above (P<0.001) and NBP group
as compared with the OBP group (P<0.001) were associated with an increase
in risk of having impaired fasting blood glucose. Smoking did not appear to
be a risk factor (P=0.915). Individuals with NBP and HNBP had similar
prevalence of impaired fasting blood glucose (30.5% vs 28.4%) (P=0.588).
Binary logistic regression revealed that older age (>50 years old) (odds ratio
(OR): 2.444, 95% confidence intervals (CI): 1.903-3.138) (P<0.001), BMI
(≥23) (OR: 2.901, 95% CI: 2.247-3.744) (P<0.001) and blood pressure at
NBP range (OR: 1.625, 95% CI: 1.232-2.143) (P=0.001) remained to be
important risk factors for the development of impaired fasting blood glucose.
Conclusions: The prevalence rates of impaired fasting blood glucose in
individuals with optimal, normal and high normal blood pressure were
15.6%, 30.5% and 28.4% respectively in Macau SAR. Increasing age, BMI
and blood pressure were important risk factors for the development of impaired
fasting blood glucose.
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Barriers in Participation in Phase II Cardiac Rehabilitation
Program: Did Latest Interventions Help?
YMW Mak, CSS Yue
Division of Cardiology, Department of Medicine and Geriatrics, United
Christian Hospital, Hong Kong
Purpose: A study was done in July 2002 to January 2003 to explore the
barriers in participation in phase II cardiac rehabilitation program (CRP) in
a regional hospital. After that study, to address barriers including physical
unfitness for or fear after exercise stress testing and work or time conflicts,
two interventions were applied. Those eligible patients could be enrolled in
training program with assessment by using six-minutes walk test or participate
in a two-session class. The purpose of this study was to review if there was
improvement in participation rate after interventions were applied.
Methods: Cardiac patients referred to phase I CRP in Year 2014 were studied.
Patients that did not participate in phase II were reviewed for their possible
barriers. The endpoint was evaluated one year after referral to CRP. The
results were compared with our previous study done in 2002 to 2003 to
determine if those two interventions could improve the participation rate in
phase II CRP.
Results: During the 12-month period, a total of 328 patients (235 males, age
range: 39-94 years) were referred to phase I CRP. Sixty-six patients proceeded
to phase II; the participation rate was 20%. As compared to previous study,
percentage of patients that could not participate in phase II CRP due to
physical disability or fear after exercise stress testing and work or time
conflicts was reduced from 52% to 44% and from 16% to 14%, respectively.
The study also showed that with the enhancement of primary percutaneous
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coronary intervention service, need to attend scheduled cardiac interventions
was reduced from 13% to 0%. The proportion of patients that preferred
exercise or managed heart problem on their own, or considered cardiac
rehabilitation non-essential was increased from 5% to 14%.
Conclusions: The study showed a trend in improvement in the participation
rate with new interventions applied to address specific barriers. However,
the overall participation rate in phase II CRP remained low. Other strategies
to address those specific barriers are warranted.
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An Evaluation on a Cardiac Nurse-led Anticoagulation Service
YW Leung, 1 CS Yue, 1 KLK Cheung, 2 WS Lai, 2 SM Li, 2 WY Leung, 2
HS Woo,2 KF Law,1 KS Chow,1 SK Tang1
1
Division of Cardiology, Department of Medicine and Geriatrics; 2Pharmacy
Department, United Christian Hospital, Hong Kong
Background: Warfarin is an effective treatment in preventing
thromboembolic event and is the recommended treatment option for patient
with prosthetic heart valve as well as valvular atrial fibrillation (AF). The
stability of international normalized ratio (INR) can be affected by factors
like patients' medication adherence and knowledge, warfarin interaction with
other drugs and food, and comorbid conditions. In order to optimize treatment
efficacy and safety, a cardiac nurse-led anticoagulation service was established
in a regional hospital. The services include interval INR monitor, phoneconsultation for sub- or supra-therapeutic INR coupled with early nurse-led
clinic assessment, as well as protocol-driven warfarin titration if indicated
before scheduled doctor clinic follow-up.
Objective: This study aims to evaluate the service outcomes from INR time
in target therapeutic range (TTR) and number of adverse event. Reasons for
sub- or supra-therapeutic INR were also analyzed.
Methodology: Data from March 2015 to February 2016 were reviewed
retrospectively.
Results: Over 6000 INR results of ~400 patients were monitored by trained
cardiac nurse, the average TTR was 72.8%. Ninety-two patients (indication:
63% for prosthetic heart valve; 31.5% for AF and 5.5% for others) with subtherapeutic (41%) or supra-therapeutic (59%) INR (+/- 0.2) were referred to
nurse-led clinic for early assessment, education and counselling, and drug

Negative Effect of Valsartan on the Expression of CaMKII by
Degenerate Phosphorylation but not Oxidation in Juvenile Rats
with Heart Failure
Y Wu, QJ Yi
Cardiovascular Center, Children's Hospital of Chongqing Medical University,
China

titration. They were aged 28 to 85 (mean 64.4; 51% female; >40% with
secondary education level or above). All cases were also referred to pharmacist
for drug counselling and drug-drug interaction screening. No major bleeding
or thromboembolic event was recorded after drug titration. Concrete reason
could not be identified. Potential causes for sub- or supra-therapeutic INR
were 78% knowledge deficit on anticoagulation care; 24% were nonadherence to treatment; 32% were suspected to have drug-drug interaction;
and 21% were having low dietary compliance.
Conclusion: The outcomes demonstrated a safe and quality nurse-led service.
In addition, the potential causes reflect the need of multidisciplinary
collaboration among parties involved in delivering anticoagulation care in
order to achieve a better patient outcome.

Conclusions: As the phosphorylation of Thr286 is associated with the early
activation of CaMKII, rather than the oxidation of Met281, our data suggest
that valsartan may exert its therapeutic effects on early-stage heart failure by
reducing the phosphorylation of CaMKII.

Background: This study was undertaken to determine the relative
contributions of phosphorylation and oxidation on the increased activity of
CaMKII in juvenile rats with cardiac myocyte dysfunction.
Methods: Juvenile rats (n=28) underwent abdominal aortic constriction
(AAC) to induce heart failure (HF) while sham-operated rats were used as a
control group (C, n=8). Four weeks post-surgery, echocardiography was
performed to evaluate left ventricular (LV) function. Rats with ventricular
dysfunction were then randomly divided into two groups: one group given
valsartan (30 mg/kg/d, intragastric) as the treatment group (V, n=8) and the
other given vehicle as the heart failure group (HF, n=10). After 4 weeks of
treatment the animals were sacrificed and Western blot analysis was employed
to quantify the phosphorylation (Thr286) and oxidation (Met281) of CaMKII
in cardiac myocytes in all groups.
Results: Four weeks after surgery, high-frequency ultrasound
echocardiography revealed that LVIDs and LVESV were increased and LVEF
and LVFS were decreased in the AAC rats compared to controls. Thr286
phosphorylation of CaMKII was increased 6.15-fold compared to group C,
while Met281 oxidation was slightly but not significantly elevated (P>0.05).
In rats treated with valsartan no significant differences in the two related
activation sites of CaMKII were found relative to group C (P>0.05).
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Role of β -catenin in the BMP9-induced Differentiation of
C3H10T1/2 Cells into Cardiomyocyte-like Cells
SH Fang, Y Chen
Children's Hospital of Chongqing Medical University, China
Objective: To investigate the role of beta-catenin in the differentiation of
C3H10T1/2 cells into cardiomyocyte-like cells induced by bone
morphogenetic protein 9 (BMP9).
Methods: C3H10T1/2 cells were infected with the recombinant adenovirus
for BMP9 and differentiated into cardiomyocytes in vitro for up to 21 days.
The active levels of beta-catenin after cultivated with BMP9 and different
concentrations of beta-catenin specific inhibitor XAV-939 were detected by
Western blotting. Real-time quantitative PCR (qRT-PCR) was performed to
evaluate the expression of cardiac specific gene myocyte enhancer factor 2C
(MEF2C) and guanine-adenine-thymine-adenine binding protein 4 (GATA4)
after one week induced by BMP9 and different concentrations of XAV-939.
Three weeks after transfection, the expressions of myocardium specific
proteins connexin 43 (CX43) and cardiac troponin T (cTnT) were analyzed
by using Western blotting, and immunofluorescence staining was used to
observe the locations of CX43 in the cells.
Results: 1) The expression of beta-catenin were significantly increased in
the protein levels, while the activation rate could be decreased with the
concentration of inhibitor XAV939 increased; 2) After XAV-939 inhibited
the activity of beta-catenin, the expressions of MEF2C, GATA4, CX43, cTnT
of C3H10T1/2 cells induced by BMP9 was significantly suppressed.
Conclusion: The beta-catenin can be actived by BMP9 and the activation of
beta-catenin plays an important role in the differentiation of C3H10T1/2 cell
into cardiomyocytes-like cells induced by BMP9.

RALDH2 is Essential for Cardiomyogenesis during P19 Stem Cell
Differentiation
LF Zhang, YH Gui
Children's Hospital of Fudan University, China
Background: Retinoic acid (RA), a bioactive derivative of vitamin A, plays
a crucial role in multiple steps of cardiovascular development. The
retinaldehyde dehydrogenase 2 (RALDH2) catalyzes the second oxidative
step in RA biosynthesis. RA deficiency is involved in impaired
cardiomyogenesis. However, the interaction of RA signaling with other
signaling pathways that stimulate or inhibit cardiomyogenesis is not fully
elucidated. To investigate the mechanism(s) underlying RA signaling in
controlling cardiomyogenesis, we determined the role RALDH2 in regulating
cardiomyogenic differentiation of murine P19 pluripotent embryonal
carcinoma cells.
Methods: Murine P19 embryonic carcinoma stem cells were utilized to
differentiate into cardiomyocytes. The RALDH2 siRNA was used to knock
down the expression RALDH2 in P19 cells. The expression levels of
cardiomyogenic related genes (Nkx2.5, WT-1, GATA4, a-MHC and CTnT)
were profiled using quantitative RT-PCR in a time-dependent manner of
differentiation.
Results: Endogenous RALDH2 levels were decreased from day 0, indicating
that down-expression of RALDH2 in the transfected cells was confirmed.
RALDH2 knock-down alters the gene expression files. The data from
quantitative real-time RT-PCR reveals changed expression levels of cardiac
muscle-specific molecular markers in RALDH2 knock-down cell lines when
compared to that in control cells during differentiation. The progenitor specific
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gene expression of Nkx2.5 was significantly up-regulated during the
cardiomyogenic differentiation of P19 cells, whereas the differentiation
related gene expression levels of GATA4, TEF-1, a-MHC and CTnT were
markedly decreased. The WT-1 were increased in the early stage of
differentiation but decreased in the late stage of differentiation.
Conclusion: These finding suggest that RA signaling is critical for cardiac
progenitor differentiation through regulation of cardiomyogenic related gene
expression. Reduction of RA signaling may restrict cardiac progenitor
differentiation through up-regulation of progenitor cell specific transcription
factor Nkx2.5.
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Effect of Lipid Metabolism Disorders on Fetal Rat Heart in SD
Rats
HJ Ba, HS Wang, L Zhu, HM Peng, YZ Qin
Department of Paediatric Cardiology, The First Affiliated Hospital of Sun
Yat-sen University, China

Conclusion: High-fat feeding of SD rats exists abnormal lipid metabolism
during pregnancy (high cholesterol, low density lipoprotein cholesterol and
low high density lipoprotein cholesterol), the fetal rat myocardial cell has
damage.

Objective: To investigate the effect of lipid metabolism disorders in SD rats
on fetal rat myocardial cell.
Methods: Select 30 clean grade SD rats, including 10 male and 20 female.
After adaptive feeding 3 days, according to the proportion of 2:1 cage for the
night, the morning inspection, if we found the sperm by vaginal smear ,it
was considered 0.5 days for pregnancy. Pregnant rats were randomly divided
into A, B two groups, each group has 10. Group A was fed with ordinary
feed, and Group B with high fat feed. Blood samples were collected to
determine blood lipid. Fetal rat myocardial tissue was taken to observe under
light microscope and electron microscope after dealing with.
Results: The lipid level is similar between the two groups before pregnancy.
At 21 days of pregnancy, compared with group A of rats, group B of rats
total cholesterol and low density lipoprotein cholesterol increased significantly
(P=0), and high-density lipoprotein cholesterol decreased obviously
(P=0.001). Under light microscopy to observe two groups of fetal rat
myocardial cell with HE staining slice, group B cell structure owes unclear,
cell edema, cell nucleus shape is irregular. Two groups of fetal rat myocardial
tissue ultrastructure observation indicated: each group A cell organelles,
complete and with clear edge structure. Rich mitochondria, mitochondrial
cristae complete, muscle wire visible lines are arranged between the
mitochondria; The sarcomere is clearly visible. Group B cell organelles, the
decrease in the number of mitochondria crest fracture; Decrease in the number
of myofibril, sarcomere fuzzy, visible fracture muscle.

Satellite-based Estimate of PM2.5 and the Association with Level
of C-reactive Protein in Taiwanese Adults
ZL Zhang,1 AKH Lau,2 THW Tam,3 LY Chang,4,5 XQ Lao1
1
Jockey Club School of Public Health and Primary Care, The Chinese University
of Hong Kong, Hong Kong; 2Institute of Environmental Science, The Hong
Kong University of Science and Technology, Hong Kong; 3Department of
Sociology, The Chinese University of Hong Kong, Hong Kong; 4Academia
Sinica, Taiwan; 5MJ Health Research Foundation, The MJ Group, Taiwan
Purpose: High-sensitivity C-reactive protein (hs-CRP) is a predictor of
cardiovascular disease and may act as a mediator in the development of
atherosclerosis. We investigated the association between long-term exposure
to fine particu late matter (particulate matter with aerodynamic diameter less
than 2.5 µm, PM2.5) and hs-CRP in a cohort of Taiwanese adults.
Methods: We performed a cross-sectional analysis using the baseline data
of the cohort consisting of 29,199 adults (59.1% men) who participated in a
standard medical screening program between 2006 and 2014. An overnight
fasting blood sample was taken and hs-CRP was measured by an automated
biochemical analyzer. Information on a wide range of potential confounders
was collected as well during the medical examination. The participants'
residential addresses were geo-coded into latitude and longitude data and
then the PM2.5 levels at the addresses 1 x 1 kilometer grid were estimated by
a remote-sensing algorithm based on the US National Aeronautics and Space
Administration satellite data. Multivariable linear regression models were
used to investigate the associations between PM exposure and hs-CRP level
adjusting for potential confounders.
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Results: Annual average concentration of PM2.5 was positively associated
with hs-CRP. Per 10 µg/m 3 increment in PM 2.5 level was associated with
2.89% increase in hs-CRP [95% confidence interval (CI): 2.14%, 3.64%;
P<0.001]. After full adjustment for age, sex, educational level, body mass
index, morbidities (hypertension, diabetes and hyperlipidemia) and lifestyle
factors (smoking, alcohol drinking, exercise and diet), the effects were slightly
attenuated but remained statistically significant (2.73% increase in hs-CRP
per 10 µg/m3 increment of PM2.5, 95%CI: 2.07%, 3.39%; P<0.001).
Conclusions: Our results indicate that long-term exposure to PM 2.5
is associated with an increased level of hs-CRP. This provides evidence
supporting a mechanistic link between long-term exposure to PM 2.5 and
deteriorating cardiovascular health.
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Protective Effects of Mesenchymal Stem Cells in Combination
with Erythropoietin in Bronchopulmonary Dysplasia-induced
Alveoli Dysplasia Injury through Angiogenesis
Y Luan, S Chao, KL Li, J Wang, Q Xin, GH Cheng, F Kong
Department of Central Research Laboratory and Urology, The Second Hospital
of Shandong University, Jinan, China

co-expressed PECAM-1 and type II alveolar epithelial cells (AEC2)-specific
marker SP-C, but not AEC1-marker AQP5.
Conclusion: Two weeks after injection of BMSCs in combination with EPO
significantly promoted lung repair after hyperoxia-induced alveoli dysplasia
injury, decreased inflammation and enhanced angiogenesis. Therefore, the
protective effect maybe through modulation of paracrine mechanism and
provides firm information for clinical trial.

Introduction: Bronchopulmonary dysplasia (BPD) is the most common
chronic lung disease of infancy, currently, no effective therapy is available
for it. The aim of the present study was to investigation the treatment effect
of bone marrow mesenchymal stem cells (BMSCs) in combination with
recombinant human erythropoietin combination (rHuEPO) in hyperoxiainduced BPD injury and discussion the mechanism.
Method: The BPD model was prepared by continuous high oxygen exposure
to 14 days, 1 x 106 BMSCs and 5000 U/kg rHuEPO were injected respectively
at 1h before and 7d after hyperoxia-exposed neonatal mice, the animals
received 4 different treatments (n=10 in each group). After raised the mice
to 14-day, the body weight and airway structure, mRNA expression of tumour
necrosis factor-alpha (TNF-α) interleukin 1 beta (IL-1β) and IL-6 , the protein
levels of nuclear factor-κB (NF-κB) and vascular endothelial growth factor
(VEGF) were detected by histology, quantitative PCR (qPCR) and western
blotting. Cell differentiation was observed type II alveolar epithelial cells
(AEC2)-specific marker surfactant protein-C (SP-C) and platelet endothelial
cell adhesion molecule-1 (PECAM-1/CD31) by immunofluorescence.
Result: Compared with BMSCs alone, the body weight, airway structure,
the levels of inflammatory cytokines and VEGF were significantly
improvement in BMSCs/EPO group. Fourteen days after engraftment, BMSCs

Tetramethylpyrazine Protects Coronary Endothelial Function
from Endoplasmic Reticulum Stress: Regulation of Soluble
Epoxide Hydrolase
SK Mak, WT Sun, XC Wang, CM Yu, Q Yang
Division of Cardiology, Department of Medicine and Therapeutics, Institute
of Vascular Medicine, Li Ka Shing Institute of Health Sciences, Institute of
Innovative Medicine, The Chinese University of Hong Kong, Hong Kong

Conclusions: ER stress mediates Ang-II-induced sEH upregulation in
coronary endothelium. TMP has potent anti-ER stress capacity through which
TMP normalizes sEH expression and confers protective effect against AngII on endothelial function of coronary arteries. These findings added new
mechanistic insight into the cardiovascular benefits of this traditional Chinese
medicine that may have potential clinical implications for the treatment of
hypertension.

Purpose: Activation of soluble epoxide hydrolase (sEH) is associated with
endothelial dysfunction in hypertension, though mechanisms of sEH activation
have been inadequately understood. Whether endoplasmic reticulum (ER)
stress is involved is yet to be studied. Tetramethylpyrazine (TMP) is an active
ingredient of Chinese herb Chuanxiong that has cardiovascular benefits.
Whether TMP possesses anti-ER stress properties to confer vasoprotection
and whether regulation of endothelial sEH is involved remains uninvestigated.
Methods: Primary cultured porcine coronary endothelial cells (PCECs) were
used for western blot and reverse-transcription PCR analysis. Myograph study
was performed to evaluate endothelial function of porcine coronary arteries.
Results: Angiotensin II (Ang-II) increased sEH expression in PCECs,
associated with upregulation of ER stress molecules including GRP78,
p-IRE1α, and ATF6. Pretreatment of PCECs with ER stress inhibitors
suppressed Ang-II-induced sEH expression. TMP showed comparable effect
to that of ER stress inhibitors against Ang-II-induced ER stress and sEH
upregulation. The anti-ER stress-mediated normalization of sEH expression
conferred by TMP was further observed in PCECs exposed to the ER stressor
tunicamycin. TMP was effective in preventing Ang-II-induced endothelial
dysfunction and the effect was comparable to that of ER stress inhibitors.
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A Tale of 3-gorges in the Yangtze River: Comparing the
Prevalence of Metabolic Syndrome According to NCEP-ATPIII,
WHO, IDF Criteria and Impact on Atherogenesis
YJ Hu,1 KS Woo,2 P Chook,2 MJ Wu,3 AN Wei,3 L Li,4 DJ Celermajer5
Nineth People's Hospital of Chongqing, China; 2The Chinese University of
Hong Kong, Hong Kong; 3Chongqing University of Medical Sciences, China;
4
Wu Shan Centre for Disease Control and Prevention, China; 5The University
of Sydney, Australia

1

Purpose: Metabolic syndrome (MS) is associated with atherosclerotic
diseases. The prevalence of MS according to Adult Treatment Panel III
(ATPIII), World Health Organization (WHO) and International Diabetes
Federation (IDF) criteria is variable but increasing in western countries and
modernizing Chinese communities. This study aims to evaluate the prevalence
of MS and impact on atherosclerotic surrogate according to these 3 criteria
in farmers or residents in 3-gorges territories undergoing a rapid lifestyle
changes related to 3-gorges dam construction.
Methods: We compared 95 residents (ex-farmers) in Wu Shan (WS) (28.4%
males, aged 49.7±9 years) resettled uphill for 3-5 years, and 87 age and gendermatched farmers in Da Chang (DC) (27.6% males, aged 48.8±10 years) prior
to resettlement. MS and other traditional risk factors were assessed, and carotid
intima-media thickness (IMT), a surrogate atherosclerotic marker, was
measured by high resolution ultrasound.
Results: 99% of WS residents were retired or adopted non-farming jobs
(P<0.0001). Compared with DC farmers, WS residents had higher waist
circumference, LDL-cholesterol and triglycerides (P<0.0001), but their blood
pressures, HDL-cholesterol and fasting glucose were similar. MS were
identified in 43.2% (IDF), 36.8% (WHO) and 29.5% (ATPIII) in WS,

Epigallocatechin Gallate (EGCG) Reverses Cardiac Troponin I
Low Expression Induced Heart Diastolic Dysfunction through
Histone Acetylation Modification in Aging Mice
B Pan, JJ Quan, ZW Xu, XP Huang, J Tan
Pediatric Cardiology, Children's Hospital of Chongqing Medical University
Investigators, China
Purpose: Cardiac diastolic dysfunction (CDD) is the most common form of
cardiovascular disorders, especially in elderly people. However the underlying
mechanisms of CDD in aging populations are still not clear, and there is also
still lack of effective interventions targeting on CDD. This study was designed
to investigate: 1) whether the diastolic dysfunction commonly observed in
older hearts is associated with the cTnI decrease and what cause a cTnI
decrease; 2) whether epigallocatechin-3-gallate (EGCG) would modify histone
acetylation events to regulate cTnI expression and then improve cardiac
functions in aging mice.
Methods: Western blotting and Quantitative-polymerase chain reaction
(Q-PCR) were used to detect cTnI expression levels; High frequency
echocardiography and transmission electron microscope (TEM) were
employed to analyze cardiac function and ultra structure of mice; DNA
methylation and histone acetylation modifications of cTnI were determined
by methylmion specific PCR/bisulfite sequencing PCR and chromatin
immunoprecipitation (ChIP).
Results: Compared to 3 month (3 m) mice, the cardiac diastolic function of
aging mice were significantly decreased, TEM showed and a destruction of
myofilament in aged mice. A lower expression of cTnI both in protein and
mRNA levels were found in aging mice compared with 3 m mice. DNA
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compared with 17.2%, 13.8% and 11.5% respectively in DC. Carotid IMT
was significantly higher in WS residents (0.74±0.16 mm) than in DC farmers
(0.64±0.11 mm) (P<0.0001). On multivariate regression analysis, carotid IMT
was better correlated with IDF criteria of MS, independent of age and LDLcholesterol and resident group.
β-Values (P-value)
Regression F-value
R-Value (P-value)

NCEP-ATPIII
0.145 (P=0.082)
11.2
0.661 (P<0.0001)

WHO
0.074 (P=0.327)
10.8
0.653 (P<0.0001)

IDF
0.269 (P=0.002)
12.8
0.685 (P<0.0001)

Conclusions: IDF MS criteria is more sensitive and better correlates with
atherosclerosis surrogate, and more applicable to the Chinese currently
undergoing rapid economic transition.

methylation level of cTnI showed no significant changes among each group.
ChIP assays demonstrated that AcH3 and AcH3K9 levels in the key-cis
elements of cTnI at 3 m were higher than that at aged stage. We then evaluated
the binding levels of transcription factors Mef2c and GATA4 with those
elements, the binding levels of both Mef2c and GATA4 were reduced in
aging hearts. Further studies demonstrated that EGCG could improve cardiac
function of aging mice, and reverse cTnI decrease through inhibiting HDAC1
binding with key-cis elements of cTnI's promoter, which may up-regulate its
histone acetylation level of the promoter and increase the binding levels of
Mef2c and GATA4 with it.
Conclusions: Our study indicates that epigenetic modification caused cTnI
expression decrease is one of the causes that result in a reduced cTnI level
and diastolic dysfunction in the older hearts, and provide new insights into
histone acetylation mechanisms of EGCG that may contribute to the
prevention of CDD in aging populations.
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The Use of Duke Activity Status Index (DASI) in Congenital Heart
Patients − A Preliminary Study
PC Chow
Department of Paediatric Cardiology, Queen Mary Hospital, Hong Kong

Background and Objectives: Assessment of exercise capacity has been part
of the clinical evaluation in patients with congenital heart disease. However,
its use is limited by the cost and availability of a well-equipped
cardiopulmonary exercise laboratory and the trained expertise to conduct the
test. Studies demonstrated the feasibility of using Duke Activity Status Index
(DASI), a 12-items validated disease-specific self-reported questionnaire, to
assess the functional capacity in patients with heart failure and patients after
cardiac surgery. Regression equation has been derived to estimate the peak
oxygen consumption (MVO2) using DASI. Data is lacking about its use in
congenital heart disease and Chinese subjects. We aimed to translate the
DASI in traditional Chinese and to test the feasibility of its use in local patients
with congenital heart disease.
Methods: The 12-items DASI questionnaire was translated into traditional
Chinese and back-translated into English for comparison with the original
English version. Modification was made to enhance the comprehension of
the items in Chinese. The translated DASI was administered to 48 patients
(25 males; mean age of 27.8±7.7 years) with congenital heart disease at the
time just before their scheduled cardiopulmonary treadmill exercise test using
Bruce protocol. Correlation between the DASI score, NYHA class, WarnesSomerville Ability Index (WSAI), Disease complexity and exercise test
variables was assessed accordingly.
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Results: Thirty-six patients (75%) were in NYHA class I, and 12 patients in
NYHA class II. For WSAI, 37 patients in grade 1 and 11 patients in grade 2.
Most of the patients' heart were of moderate complexity (N = 30), with 17 of
great complexity and 1 of simple complexity. The mean DASI score was
41.2±11.8. Internal consistency of the DASI items as reflected by Cronbach's
alpha was 0.78. The mean MVO2 was 28.20±6.95 ml.kg-1.min-1 and the mean
exercise duration was 9.21±2.19minutes. DASI was significantly correlated
with age (r=-0.33, p=0.23), NYHA class (rs=-0.031, p<0.05), WSAI (rs=
-0.35, p<0.05), complexity (rs=-0.33, p<0.05), MVO2 (r=0.46, p=0.001) and
exercise duration (r=0.55, p<0.001). MVO2 was not significantly different
among different NYHA classes, WSAI grades and disease complexity. MOV2
and exercise duration was predicted by DASI in regression analysis as: MVO2
(ml.kg -1.min -1) = 0.269 x DASI + 17.1 and Exercise duration (minute) =
0.103 x DASI + 4.985 respectively.
Conclusions: The translated DASI is a feasible instrument to assess the
functional capacity in Chinese patients with congenital heart diseases. Further
studies may help confirm its use in formal assessment and follow-up of
patients.
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C Chu, 1 XC Liang, 1 SN Sun, 1 F Wang, 1 L Zhao, 1 QM Zhao, 1 Y Guo, 2
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1
Children's Hospital of Fudan University; 2Shanghai Children's Medical
Center; 3Children's Hospital of Shanghai Jiaotong University, China
Objective: To find the most optimal intravenous immunoglobulin (IVIG)
treatment regimen in acute Kawasaki Disease (KD) through an investigation
of three regimens and their respective effects on clinical characteristics and
coronary artery changes in acute KD though a multicentre randomised control
study.
Methods: Between January 2014 and December 2015, a prospective
randomised control study was performed at three children's hospitals in
Shanghai, China in children between 1 month to 12 years of age with a
confirmed diagnosis of acute untreated KD. After consent was obtained from
a legal guardian, subjects were divided into three groups using simple
randomisation. Group A received IVIG 2 g/kg once over 12-24 hours; group
B received IVIG 1 g/kg twice, administered over two days; group C received
IVIG 1 g/kg once over 12-24 hours. Patients in all three groups received
IVIG within 5 to 10 days of onset of symptoms, and were simultaneously
administered aspirin at 30-50 mg/kg/d split into three doses per day. Patients
who did not respond to initial IVIG therapy were given a second dose of
IVIG 36 hours after the initial dose at 2 g/kg. Patients who did not respond to
the second dose of IVIG were given either high-dose pulse therapy of
methylprednisolone 10-20 mg/kg/d or TNF-α antagonist (infliximab) therapy.
Patient demographics and clinical and laboratory test changes, including
temperature, white blood cell count (WBC), C-reactive protein (CRP), platelet
count (PLT), erythrocyte sedimentation rate (ESR), serum albumin, serum
sodium, and alanine transaminase (ALT) through the course of disease were
recorded. Length of stay in hospital and cost were also recorded, in addition
to any adverse effects during course of treatment. Follow-up data, including
echocardiography at different phases of disease, were statistically analysed.
This trial is registered with ClinicalTrials.gov, number NCT0239996.
Results: 397 patients met inclusion criteria, of which 249 were males and
148 were female (male to female ratio = 1.682:1). Group A had 138 patients
(34.80%), with an average age of 26.43±22.698 months and average weight
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of 12.48±4.381 kg. Of these patients, 13 (9.42%) had incomplete Kawasaki
Disease (IKD). Group B had 127 patients (32.00%), with an average
age of 28.82±22.266 months and average weight of 13.23±5.154 kg, with 15
cases (11.81%) of IKD. Group C had 132 patients (33.25%), with an average
age of 26.13±20.039 months and average weight of 12.96±5.726 kg, with 15
cases (11.36%) of IKD. There was no significant difference in age, weight,
sex ratio, or IKD ratio between the three groups (P>0.05) with appropriate
comparability. No statistical difference was found between the three groups
in clinical characteristics and pre-treatment laboratory results (P>0.05).
Coronary changes within the first ten days of disease onset were detected in
57 patients (14.35%), of which 21 were from Group A, 19 were from Group
B, and 17 were from Group C, with no significant difference among the three
groups. At one month after disease onset, grade II coronary changes were
detected in 29 patients (12 in Group A, 7 in Group B, 10 in Group C), grade
III coronary changes were detected in 25 patients (9 in Group A, 10 in Group
B, 6 in Group C), grade IV coronary changes were detected in 3 patients
(none in Group A, 2 in Group B, 1 in Group C). When incidence of coronary
changes was compared between the three groups, no significant difference
was found (P=0.634). There was no significant difference in duration of fever
prior to admission. After treatment, time to defervescence for groups A, B,
and C were 1.083±0.749, 1.039±0.686, and 1.110±0.737 days, respectively,
with no significant difference between the groups (P=0.733). There was also
no significant difference in total days of fever between the groups. There
was no significant difference between the groups in the number of patients
who were not responsive to initial IVIG therapy. Between the three groups,
WBC, CRP, and ALT levels all decreased after IVIG therapy, while PLT
increased. There was no significant difference in magnitude of change between
the three groups. There was no significant difference in length of stay in
hospital, but Group B had the highest cost and Group C had the lowest cost
(P=0.0002). Group C had the best cost-benefit ratio among the three groups.
Conclusion: For patients with acute KD, IVIG administered in a single
1 g/kg dose, when compared with 1 g/kg over two days and a single 2 g/kg
dose, have comparable effects on time to defervesecence, prevention of
coronary changes, and improvement of laboratory test results. However, the
1 g/kg single dose regimen can significantly reduce the cost of treatment.
Further studies on IVIG treatment regimens in KD in more centres and in a
mixed ethnic population are warranted.
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Objective: We sought to define the characteristics that distinguish Kawasaki
disease shock syndrome (KDSS) from hemodynamically normal Kawasaki
disease.
Methods: We collected data prospectively for all patients with Kawasaki
disease who were treated at a single institution during a 2-year period. We
defined Kawasaki disease shock syndrome on the basis of systolic hypotension
for age, a sustained decrease in systolic blood pressure from baseline of ≥20%,
or clinical signs of poor perfusion. We compared clinical and laboratory
features, coronary artery measurements, and responses to therapy and analyzed
indices of ventricular systolic and diastolic function during acute and
convalescent Kawasaki disease.
Results: Of 231 consecutive patients with Kawasaki disease, 4 (1.73%) met
the definition for KDSS. All required fluid resuscitation and vasoactive
infusions. Compared with patients without shock, patients with Kawasaki
disease shock syndrome were more often female, the age of patients with
KDSS was between 5.2 to 8.9 years, as well as had larger proportions of
bands, higher C-reactive protein concentrations, and lower hemoglobin
concentrations and platelet counts. Evidence of consumptive coagulopathy
was common in the KDSS group. Patients with KDSS more often had impaired
left ventricular systolic function (All ejection fraction <54% [100.00%] vs

FECI (Focused Echocardiographic Coronary Imaging): A Novel
Systemic Approach for Identifying & Detecting Coronary
Abnormalities in Kawasaki Disease
KS Hsieh, IH Tai, CC Lin, IC Lin, HC Kuo, HW Wu, YC Hong, MH Lo,
CF Huang, YJ Lin, HC Kuo
Division of Cardiology, Department of Pediatrics, Chang Gung, Memorial
Hospital, Taiwan
Background: Kawasaki disease (KD) may induce coronary artery
abnormalities (CAA) ranging from transient ectasia, small aneurysm to giant
aneurysm. The incidence of CAA used to be around 5-10% after acute phase
of KD. Based on our experience, coronary arteries dimensions alone may be
misclassified as normal in acute KD. There had been scanty information
about the systemic approach to examine the status of coronary arteries in
children with KD. We thus proposed & developed a novel focused
echocardiographic coronary imaging (FECI) approach.
Methods: Between July 2013 and June 2014, a total of 35 patients with
acute phase KD was enrolled, and 100 normal pediatric patients was used for
control. We employed commercially available ultrasonoscope for
examination. All the patients were examined at diagnosis, 1, 2 and 6-8 weeks
after the onset of illness. Assessment of right coronary (proximal and distal
portions), left main (middle portion), left anterior descending (proximal and
distal portions) and circumflex arteries (proximal portion) was performed in
each patients. CAA is considered at the presence of any of the following:
1) dilatation or aneurysm formation 2) lack of tapering 3) irregularity
4) intimal enhancement with brightness in the coronary arterial wall.
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22 of 227 patients [9.69%]), mitral regurgitation (3 of 4 patients [75.00%] vs
31 of 227 patients [13.66%]), coronary artery abnormalities (3 of 4 patients
[75.00%] vs 18 of 227 patients [7.92%]), and intravenous immunoglobulin
resistance (4 of 4 patients [100.00%] vs 46 of 227 patients [20.26%]).
Impairment of ventricular relaxation and compliance persisted among patients
with KDSS after the resolution of other hemodynamic disturbances.
Conclusions: Patients with KDSS may have uneven clinical course and may
be misdiagnosed in the beginning. They may have more prominent
inflammatory markers in the early phase and higher risk of coronary artery
dilatation.

Results: Various CAA were present in acute KD, include various degree of
dilatation in 11 (31%), aneurysm formation in 2 (6%), lack of tapering in 13
(37%), irregularity in 12 (34%), and intimal thickening (brightness) in 23
(65%) patients respectively. Overall, CAA was present in 32 (91%) of our
patients in acute KD.
Conclusion: Our result showed that the incidence of CAA in acute KD is
higher than previously reported. Echocardiography can provide an accurate
and timely diagnosis regarding the presence of cardiac and coronary artery
lesions in acute KD. With our novel FECI method, more detailed and
comprehensive features of CAA other than coronary aneurysm and dilatation
can be provided through this systemic approach.
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CHD cases with significant differences compared to healthy ones. In
postoperative near term, significant change in NAA/Cr and NAA/Cho were
found. However, the difference was not found in follow up.
Conclusion: The meta-analysis demonstrated the delay in neurological
development in newborns with congenital heart disease, and cardiac surgery
might lead to mild brain injuries postoperatively, but recovery of fMRI
evaluation has been identified during the follow-up.

Objective: No consensus has been reached regarding whether congenital
heart disease (CHD) related brain injury is caused by cardiac surgery or
prenatal injury of CHD. We performed this meta-analysis to identify the
likely cause of adverse neurological performance in CHD patients.
Methods: Literature search was done in December 2013 and records were
retrieved from PubMed, Embase, the Cochrane Library and WHO trails center
without language restriction. Studies applying functional magnetic resonance
imaging (fMRI) evaluation of brain function before and after surgery were
included. The preoperative and postoperative fMRI results were extracted,
and meta-analysis was performed using Revman 5.1.1and STATA 11.0,
according to the guidelines from the Cochrane review group and the MOOSE
guidance.
Results: A total of 937 citations were yielded from electronic search. Fulltexts were retrieved for 16 articles and the following studies were eligible for
inclusion: 6 studies (n=327 cases) with fMRI analysis before surgery and 3
studies (n=36 cases) with completing perioperative fMRI analysis. The overall
average diffusivity of CHD cases was significant higher with a summarized
Std. Mean Difference of 1.39 (95% CI=0.70, 2.08), and the fractional
anisotropy was lower in CHD cases with a summarized Std. Mean Difference
of-1.34 (95% CI=-1.64, -1.04). NAA/Cho and Lac/Cho were recorded in

Analysis of the Clinical Value of Selective Coronary Angiography
in Children with Coronary Lesions Caused by Kawasaki Disease
(A Report of Six Cases)

Conclusion: Selective angiography of coronary artery lesions is a safe,
effective, accurate way to estimate coronary artery lesions in KD children,

L Hu, YF Li, ZW Zhang, ZF Xie, GH Zeng
Guangdong Cardiovascular Institute, China
Objective: To analyze the clinical value of selective coronary angiography
(SCAG) to the coronary lesions caused by Kawasaki disease (KD) in children,
and explore the significance of SCAG to the interventional therapy.
Method: 6 children are in the age of 2-14 years old, the median age was 7.5
years old; all of them have a clear history of KD. Transthoracic
echocardiography (TTE) showed them had coronary artery lesions more or
less, including heart failure and myocardial infarction of 2 cases. Six cases
were examined by SCAG, according to the results, 2 cases proceeded
intravascular ultrasound (IVUS), another 2 cases underwent percutaneous
balloon angioplasty, and another child received coronary artery stent
implantation.
Results: SCAG results showed that 6 cases had different degree of coronary
artery lesions. Case 1 got coronary artery dilatation but no aneurysm
formation, and there was no clinical symptom, such as chest pain, so that no
interventional therapy taken; 2 cases had coronary artery aneurysm without
obvious stenosis, both of them underwent IVUS evaluation of the coronary
artery wall, but without further intervention; 3 cases showed coronary artery
aneurysms combined with stenosis, and two of them took percutaneous balloon
angioplasty, the stenosis totally or partially relieved; the rest one got
percutaneous coronary artery stent implantation.
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Recurrent Hemoptysis of Pulmonary Vascular Anomalies in
Children − A Series of 11 Cases treated with Catheter-based
Therapy
HY Kuang, TW Lu, QJ Yi, J Tian
Department of Cardiology, Children's Hospital of Chongqing Medical
University, China
Objective: Catheter-based therapy is as the first-line management for
hemoptysis related to pulmonary vascular anomalies. This study is determined
to summarize the data of recurrent hemoptysis after catheterization, to probe
into factors, eventually to set up a suitable method, aiming at decreasing or
avoiding the recurrence.
Method: A retrospective review of 16 cases suffered from hemoptysis. After
underwent a standard medical conservative management, the clinical
manifestations got an unobvious relief. Patients were suspected or confirmed
diagnosed as hemoptysis of vascular anomalies via chest X-ray (CXR),
bronchoscope, computed tomography angiography (CTA) and digital
subtraction angiography (DSA), a golden standard of cardiovascular disease
examination, clearly detecting the origination, site and diameter of culprit
vessels. For cases managed with Cardiofix, DSA evaluates the instant plugging
effect and as a long term follow-up tool. While clinical characteristics are
administrated periodically.
Result: All patients were with diverse degrees of hemoptysis, and imaging
outcomes which presented 14 cases (87.5%) with aortopulmonary collateral
circulation, 1 case (6.25%) with pulmonary arteriovenus fistula (PAVF), and
1 case (6.25%) with bronchial artery to pulmonary circulation shunt (BPS).
Ultimately, 1 case (6.25%) received a ligation management via thoracoscope,
1 case (6.25%) selected a lung resection, and both displaying an effective

The Meta Analysis of Infective Endocarditis in Chinese Children
Q Hu, Y Chen
Department of Cardiology, Children's Hospital of Chongqing Medical
University, China
Objective: A meta-analysis was conducted to summarize Chinese children
estimates of the clinical characteristics, complications, treatment and
outcomes of infective endocarditis by R statistical software.
Methods: Four main electronic databases (WanFang database, VIP database,
China National Knowledge Infrastructure and PubMed database) was
systematically and inclusively searched for all IE studies with Chinese
children through March 2016. Meta-analysis was conducted by using
R.3.2.2. Pooled values and 95% CIs were generated from a fixed-effects model
or from a random-effects model according to statistical tests for heterogeneity.
Publication bias was assessed by using the Egger test, meta-regression and
subgroup analyses was employed to examine the effect of study-level
variables.
Results: Sixteen studies were selected with a total of 892 IE, the pooled
proportion of male was 55% (95%CI: 51%-58%). The pooled proportion of
IE with CHD was 68% (95%CI: 62%-72%), and 33% (95%CI: 27%-40%)
was VSD. The pooled rate of IE with RHD was 10% (95%CI: 7%-14%). The
most common clinical manifestation was fever (89% [95%CI: 84%-93%]).
The pooled rate of embolism and heart failure were 22% (95%CI: 19%-26%)
and 45% (95%CI: 34%-56%). Among positive blood culture, the pooled rate
of gram-positive bacterium was 87 (95%CI: 83%-90%), followed by fungus
(5% [95%CI: 3%-8%]) and gram-negative bacterium (9 [95%CI: 7%-13%]).
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prognosis for a long term follow-up. Other 11 cases (68.75%) were treated
with a catheterization, and then DSA displayed that there existed a few residual
shunts instantly, which mostly were to decrease gradually in next several
months. However, 3 patients, roughly 27.3% were readmitted to hospital for
an obvious remitting hemoptysis in one year. All presented aortopulmanory
collateral arteries that are of a large amounts, unequal-diameters and tortuous
routes. Therapeutically, 2 cases were undertaken for twice occlusion, 1 case
for 3 times.
Conclusion: Vascular correlation hemoptysis happened to elderly children
significantly, about 5-12 years. And Cather-based management is as primary
therapeutic tool for it, after which recurrence is not rare. As to recurring
episodes with collateral arteries, gaining and summarizing an accurate
imaging findings, selecting a suitable management are the key procedures.

The pooled rates of left heart and right heart were affected in 60% (95%CI:
43%-75%) and 33% (95%CI: 21%-48%). The pooled proportion of casechildren with surgical treatment was 21% (95%CI: 13%-32%). The pooled
case-fatality rate for IE was 14% (95%CI: 10%-18%), and it was different
from place to place.
Conclusion: IE was associated with significant mortality in Chinese children,
and the case-fatality rate for it could vary depending on the area. The incidence
rate of IE had nothing to do with gender. CHD was the major risk factor for
IE; however, RHD was also an important risk factor. Staphylococcus aureus
was the main pathogens of the cases of IE. The left heart was affected in
more episodes than the right heart.
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P Huang, JM Zeng, L Zhang, ZP Wang, XF Xie, SL Xia, MH Yu
Department of Pediatrics, Guangzhou Women and Children's Medical Center,
China
Background: Although undergone successful surgery of coarctation of aorta
(CoA), long-term mortality remains high attributable to cardiovascular
complication. In general, it seems well in midterm follow-up without
hypertension, ventricular hypertrophy, but structural and functional
abnormalities can be found, even repaired in childhood. The aim of the present
study is to evaluate the peripheral endothelial function in children with 4
years follow-up (from January 2010 to December 2014) after successfully
repaired of CoA.
Methods: A group of 20 children (range 4 days to 10 years, mean 1.69 years
old) who after successful CoA repair between January 2010 and October
2010 in Guangzhou Women and Children's Medical Center was studied. There
were 14 males and 6 females in CoA group, which comprised 6 patients with
isolated CoA and the others with combined heart malformations, including
12 children operated before 6 months (early surgery group) and 8 children
operated after 6 months (non early surgery group). And 20 healthy children
for health physical examination at the same time were enrolled as control
group. All subjects underwent monitoring of resting blood pressure,
echocardiography and flow-mediated dilation (FMD) of the brachial artery,
before operation or blank intervention and 4 years follow-up.

Result: There were no resting hypertension in all subjects in 4 years of followup. And no recoarctation and pseudoaneurysm occurred in CoA group, but
brachial artery FMD in CoA group was higher than control group, both before
operation or blank, 1 year and 4 years after that (P<0.05). But there were no
statistical differences between early surgery group and non early surgery
group in the above period respectively (P>0.05).
Conclusion: Although all children were normotensive in the mid-term followup after successful repair, endothelial damage could be found characterized
by reduced brachial artery FMD, which indicated that operation could cure
the mechanical obstruction of the aorta, but not the vascular function. And
early surgery does not lessen vascular endothelia impairment.

PAEDIATRIC CARDIOLOGY II
Successful Transcatheter Occlusion of Giant Coronary Artery
Fistula in a Young Infant: Case Report and Literature Review
XD Li, HS Wang
Department of Pediatric Cardiology, 1st Affiliated Hospital of Sun Yat-Sen
University, China
Congenital coronary artery fistula is a rare anomaly with different clinical
manifestation. A giant one can cause heart failure and 'steal' phenomenon by
large amount of left to right shunt. Recently, transcatheter occlusion for
congenital coronary artery fistula has been advocated as an effective alternative
to surgical repair in children and adult patients, but in infant it is still a
challenge. We report a 22-day-old infant who had tachycardia, tachypnea,
interrupted feeding, repeated and transient pale face, cardiomegaly, continuous
murmur, a 7 mm fistula at the narrowest point from right coronary artery to
right ventricle demonstrated by angiogram, and a large amount of shunt with
Qp/Qs equal to 3.6, and who underwent successful transcatheter occlusion
by an Amplatzer Vascular Plug II one month after admission. At review 3
months after device occlusion showed that myocardial enzyme analysis,
electrocardiography, and echocardiography were normal.
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Association of Patient Laboratory Variables and Serum Levels
of Cytokines with Coronary Artery Lesions in Acute Phase of
Kawasaki Disease
F Gao, X Zhou, SK Yadav, SQ Feng, QJ Yi
Heart Center, Childern's Hospital of Chongqing Medical University, China
Background: Kawasaki disease (KD) is the most common cause of acquired
cardiac disease in developed countries. Imbalance between Th1 and Th2
immune responses may play an important role in the development of KD. In
the present study, we explored the serum levels and the ratio of TNF-α and
IL-5, and the correlation of TNF-α and IL-5 with other laboratory variables
of the patients with coronary artery lesions in acute phase of Kawasaki
Disease.
Methods: The present study included 42 children with KD. We also recruited
30 diseased control subjects and 26 healthy subjects. Serum concentrations
of TNF-α and IL-5 were assayed using a commercially available enzymelinked immunosorbent assay (ELISA).
Results: IL-5 levels were significantly higher in KD patients with CALs
compared with KD patients without. Higher serum levels of TNF-α were
also observed in KD patients with CALs compared to KD patients without
CALs; however, the difference was not significant. There were statistically
significant differences in neutrophilic granulocytes (N) and lymphocytes (L)
between KD patients with and without CALs.
Conclusion: CALs may be associated with increased levels of neutrophilic
granulocytes, TNF-α and IL-5. Furthermore, activation of Th1 and Th2 cells
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Clinical Analysis and Follow-up of Kawasaki Disease Infants Less
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Center, China

Conclusion: Attention should be aroused to the infants less than 3 months
with fever lasting longer than 5 days if treatment shows no effect. Therefore,
they are helpful for early diagnosis such as in time examine of coronary artery
abnormalities, ESR and CRP, especially platelet change.

Objective: To analyze the clinical feature and follow-up of infants aged <3
months suffering from Kawasaki disease (KD), to increase early diagnosis of
KD and minimize the occurrence of coronary artery complications.
Methods: The data of 31 cases with infant less than three months KD admitted
from January of 2009 to June of 2013 were analyzed retrospectively in our
hospital.
Results: Of 1107 patients with KD, 2.8% were less than three months. Malefemale ratio of infant KD was 4.17:1. The incidence of the atypical KD was
higher, the incomplete KD accounted for about 51.6%. In the principal clinical
features, the clinical manifestation of the incomplete group performed lowly
in acute stage. Respiratory infection and diarrhea were occurred in the almost
half of 31 cases. The number of white blood cell, C-reactive protein (CRP) and
erythrocyte sedimentation rate (ESR) was statistically higher, but there was no
significant difference in the inflammatory findings between classic and
incomplete KD (P>0.05). The rate of coronary artery lesion of incomplete cases
appeared to be similar to that of classic cases (P>0.05), Coronary artery
abnormalities were seen in 83.9% (20/31). The prevalence of coronary artery
aneurysms with KD was 9.7% (3/31). In this group of patients with median
follow-up period was 13 months (6 to 35) showed that about 90% of infants
had normal coronary arteries after standard therapy.

The Association between Renin-angiotensin System Gene
Polymorphism and Risk of Hypertension in Pediatric Patients:
A Meta-Analysis
BB Ye, DY Su, DL Liu, SY Qin, JQ Lao, YS Pang
Department of Pediatrics, The First Affiliated Hospital of Guangxi Medical
University, China
Objective: To explore the association between the genetic markers ACE (I/D),
AGT (M235T), AT1R (A1166C) and risk of hypertension in pediatric patients.
Methods: EMBASE, PubMed, Hartford User Group Exchange (HUGE), CNKI,
VIP, Wanfang data and CBM database were searched for the case-control studies
on the association of three gene polymorphisms with hypertension in pediatric
patients from the establishment to 1st March 2016. Data extraction, quality
assessment, pooled analysis was conducted. Meta-analysis on the association
of three gene polymorphisms with hypertension between hypertension group
and control group under recessiveness, dominance, co-dominance, addition
and allele gene models was performed. Statistical analyses were analyzed by
Stata12.0 software.
Results: A total of 969 patients and 1875 controls in 8 studies with moderate
bias risk were included. An increased risk of ACE (I/D) D variant with 7 included
studies in the meta-analysis under recessive model (OR=1.355, 95%CI =
1.063-1.727, P=0.014) and dominant model (OR=1.369, 95%CI =1.080-1.736,
P=0.009). Neither ANG (M235T) polymorphism with 3 enrolled studies nor
AT1R (A1166C) polymorphism with 2 enrolled studies was found to have
significant association with hypertension in pediatric population under
recessiveness, dominance, co-dominance, addition and allele gene models.
Subgroup analysis revealed that ACE (I/D) D variant was associated with an
increased risk of hypertension in obese pediatric population under recessive
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model (OR=1.564, 95%CI=1.054-2.321, P=0.026), additive model
(OR=2.017, 95%CI=1.137-3.576, P=0.016) and allele model (OR=1.406,
95%CI=1.076-1.838, P=0.013). There were no significant differences in
the frequencies distribution of ACE (I/D) between two groups in general
population by considering ethnicity and classification of hypertension.
Conclusions: No significant association was found between ANG M235T, AT1R
A1166C polymorphisms and hypertension in pediatric population. The ACE
(I/D) polymorphism was found to have association with susceptibility to
hypertension in the obese pediatric population.
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Comparative Study between Cardiovascular Cast and Prenatal
Echocardiography in the Demonstration of Fetal Congenital
Cardiovascular Disease

Objective: To compare the demonstration accuracy of fetal cardiac chambers
and great vessels by cardiovascular casting and prenatal echocardiography.

Methods: From March 2014 to June 2015, 18 fetal specimens prenatally
diagnosed with congenital cardiovascular disease were enrolled in this study.
Prenatal echocardiography findings of these 18 cases were reviewed and
analyzed. Fetal cardiovascular cast models were made by injecting ABS
perfusate via umbilical vein. All the cast models were carefully observed
and analyzed, and cast findings were compared with prenatal diagnosis in
overall level, atrioventricular level and great vascular level.
Results: In 18 cases, 94 abnormalities were diagnosed by prenatal
echocardiography, including 48 atrioventricular abnormalities and 46 great
vascular abnormalities. Eighteen fetal specimens were all successfully
made into cast models. A total of 117 anomalies were detected in cast
models, including 35 anomalies in atrioventricular level and 82 anomalies

Figure 1. Cast demonstration of a fetus with double-outlet right ventricle (DORV),
ventricular septal defect (VSD), dilated and tortuous DA (Case 1). (A) Right
anterior 45° view: AO and PA are both originated from right ventricle (RV). (B)
Left anterior 45° view: The overriding ratio of aortic root is approximately 8090%. The dotted line represents the position of aortic root. An abnormal connection
between left and right ventricle indicates the existence of a VSD (white asterisk).
(C) Posterior view: A dilated and tortuous DA connects PA and the left posterior
wall of DAo(white arrow). (D) Right side view: SVC, IVC and LIV connect to
right atrium. (E) Prenatal echocardiography showed an overriding aorta (overriding
ratio: 80-90%) and a large VSD. (F) Prenatal echocardiography showed PA
originated from RV.
AO, aorta; DA, ductus arteriosus; DAo, descending aorta; IVC, inferior vena cava;
LAA, left atrial appendage; LIV, left innominate vein; LV, left ventricle; PA, pulmonary
artery; RAA, right atrial appendage; RV, right ventricle; SVC, superior vena cava.

Figure 2. Cast demonstration of a fetus with VSD, right aortic arch, subaortic
LIV, anomalous DA connection, etc. (Case 2). (A) Anterior view: An abnormal
connection between ventricles indicates the existence of a large ventricular septal
defect (white asterisk). Subaortic LIV is detected coursing anomalously under
the aortic arch. (B) Left side view: Ascending aorta (AAo) is originated from the
left lateral border of LV. (C) Left posterior 45° view: DA anomalously connects
DAo and RPA. (D) Right side view: Aortic arch abnormally coursed from leftanterior to right-posterior, confirming a right aortic arch. (E) Prenatal
echocardiography showed dextroversion of the heart, AO and MPA both originated
from mRV, pulmonary valvular atresia and PA stenosis. (F) Aortic arch located on
the right side of trachea and subaortic LIV was mistakenly identified as LSVC in
the prenatal sonography.
AAo, ascending aorta; Arch: aortic arch; DA, ductus arteriosus; DAo, descending
aorta; IVC, inferior vena cava; LAA, left atrial appendage; LIV, left innominate
vein; LPA, left pulmonary artery; LV, left ventricle; MPA, main pulmonary artery;
RA, right atrium; RAA, right atrial appendage; RIV, right innominate vein; RPA,
right pulmonary artery; RV, right ventricle; SVC, superior vena cava.

Y Wang,1 HY Cao,1 MX Xie,1 L He,1 W Han,1 L Hong,1 Y Peng,1 YF Hu,1
BC Song,2 J Wang,1 B Wang,1 C Deng1
1
Department of Ultrasound, Union Hospital, Tongji Medical College,
Huazhong University of Science and Technology, Hubei Provincial Key
Laboratory of Molecular Imaging; 2Laboratory of Anatomy, Tongji Medical
College, Huazhong University of Science and Technology, China
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in great vascular level. When comparing the sonographic results and cast
findings, we found 65 abnormalities were identified by both methods,
including 29 and 36 abnormalities in atrioventricular and great vascular
level, separately. There were 65 misdiagnosis in prenatal
echocardiographic findings, which were corrected or added by casts,
including 12 atrioventricular abnormalities and 53 great vascular
abnormalities. However, there were also 18 malformations observed by
fetal echocardiography could not be demonstrated in the cast models,

Figure 3. Cast demonstration of a fetus with hypoplastic left heart syndrome
(HLHS), double outlet right ventricle (DORV), pulmonary valve atresia (PVA),
pulmonary artery stenosis (PAS), ventricular septal defect (VSD), etc. (case 10).
(A) Left anterior 30° view: AAo and PA are both originated from RV.
A disconnection between RV and PA indicates the pulmonary valve atresia (white
arrowhead). (B) Left anterior 45° view: Pulmonary trunk and left/right pulmonary
artery are narrowed. An abnormal connection between RV and hypoplastic LV
suggests a ventricular septal defect (white asterisk). (C) Right posterior 45° view:
A tortuous DA connects PA and DAo. RBA and LCCA have a common trunk in
the initial segment. (D) Right side view: Dialted AO anomalously originated from
RV. (E) Prenatal echocardiography showed pulmonary stenosis. (F) A large VSD
was showed in the prenatal sonography.
AAo, ascending aorta; Arch: aortic arch; DAo, descending aorta; MPA, main
pulmonary artery; LPA, left pulmonary artery; DA, ductus arteriosus; SVC, superior
vena cava; IVC, inferior vena cava; LIV, left innominate vein; LV, left ventricle;
RV, right ventricle; LAA, left atrial appendage; RAA, right atrial appendage;
LCCA, left common carotid artery; RBA, right brachiocephalic artery.
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including 16 atrioventricular malformations and 2 great vascular
malformations.
Conclusion: Fetal cardiovascular cast has more advantages in
demonstrating anomalies of great vessels and their branches, but has some
limitations in displaying intracardiac abnormalities. Cast models may help
to understand the anatomic structure and spatial relationship of fetal
congenital cardiovascular disease, which plays a vital role in prenatal
diagnosis and clinical management.

Figure 4. Cast demonstration of a fetus with atrial situs inversus, common
atrium, single ventricle (SV), persistent left superior vena cava (LSVC), etc.
(case 11). (A) Anterior view: The enlarged AO is originated from single
ventricle. The left and right SVC are both connected with the common atrium.
(B) Posterior view: DAo locates in the right side, while IVC locates in the
left. (C) Right side view: A finger-like LAA locates in the upper right of SV.
(D) Left side view: A triangle-like RAA locates in the upper left of SV. IVC
and LSVC connect to the left side of common atrium. (E) Prenatal
echocardiography showed a single atrium and single ventricle. (F) Prenatal
echocardiography showed pulmonary stenosis.
AO, aorta; Arch: aortic arch; DAo, descending aorta; LSVC, left superior vena
cava; RSVC, right superior vena cava; IVC, inferior vena cava; SV, single
ventricle; RV, right ventricle; LAA, left atrial appendage; RAA, right atrial
appendage.
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Outcomes of Transcatheter Occlusion of Patent Ductus Ateriouses
in Infants ≤6 Months

KY Zhou, YM Hua
Department of Pediatric Cardiology, West China Second University Hospital,
Sichuan University; Key Laboratory of Obstetric & Gynecologic and Pediatric
Diseases and Birth Defects of Ministry of Education, China
Objectives: We sought to analyze the outcomes of transcatheter patent ductus
arteriosus (PDA) occlusion using a variety of devices in infants ≤6 months
and discuss the transcatheter occlusion indication of PDA in early infants.
Methods: We performed a retrospective analysis of children ≤6 mouths in
whom transcatheter PDA occlusion was attempted between January 2002
and November 2014 at West China Second University Hospital.
Results: A total of 72 patients underwent successful transcatheter device
closure. The mean age at catheterization was 4.9±1.8 months (1-6 months)
with a mean weight at catheterization of 5.1±1.9 kg (1.9-6.7 kg), the mean
PDA diameter of 3.9±0.8 mm (1.8-5.3 mm), the mean systolic pulmonary
arteriosus pressure of 55.7±8.9 mmHg (46-79 mmHg). Among these suffered
infants, companied with 72 cases of growth retardation, 48 cases of recurrent
lower respiratory tract infection, 35 cases associated with congestive heart
failure, and 5 cases of respirator-oxygen-dependent. 4/6-8/10 PDA occluder
was selected for transcatheter device closure, and intraoperative blood
transfusion were performed in 46 cases. All subjects resulted with occluder
position in good shape, no residual shunt; whileas 16 cases with aortic blood
flow velocity increased slightly, 12 cases with left pulmonary artery blood
flow velocity increased slightly just post-operation. And in follow-ups the
increased velocity of and pulmonary blood flow gradually returned to normal.
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Follow-up data showed, all subjects resulted good outcomes with growth
significantly improved, congestive heart failure cured and repeated lower
respiratory tract infection significantly reduced postoperative.
Conclusions: In experienced heart center, percutaneous closure of PDA
should be considered even in infants ≤6 months. The indications include
PDA infants with respirator-oxygen-dependent, congestive heart failure, and
recurrent lower respiratory tract infection and growth retardation. Children
underwent PDA occlusion would result with improved growth and
development, recovered heart function and less lower respiratory tract
infection.
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One Case of Right Atrial Haemangioma: Prenatal Diagnosis and
Treatment Strategy
CC Pang, W Pan, J Zhuang, CB Zhou, FZ Han
Department of Cardiac Maternal-Fetal Medicine, Guangdong Provincial Key
Laboratory of South China Structural Heart Disease, Guangdong Guangdong
Academy of Medical Sciences, Guangdong General Hospital, Guangdong
Cardiovascular Institute, China
The most common cardiac tumors of fetus are rhabdomyoma, teratoma and
fibroma. Cardiac hemangioma is one of the rarest types of cardiac tumors
and is usually diagnosed postnatally. We present here a fetus with such a
large right atrial hemangioma diagnosed in-utero with fetal echocardiography
(Figure 1), and further characterized with magnetic resonance imaging (MRI)
(Figure 2) at 30 weeks' gestation in December 2015 which is normal at 24
weeks' gestation. With the use of fetal echocardiography, a large mixed
echogenic mass protruding outward from the right atrial wall was observed.
Moderate amounts of pericardial effusion were also found. Then we checked
the tumor periodically by fetal echocardiography and detected which grow
rapidly, obstruct the inflow of the right ventricle and cause bradycardia. The
treatment time and strategy were formulated by obstetrics, pediatric
cardiologist, pediatric cardiac surgeon and neonatologist immediately. Because
of possibility of hemodynamic instability of fetal, at 32 weeks of gestation,
the women underwent a cesarean section to terminate the pregnancy. The
pediatric cardiac surgeon open the male fetus's pericardium and put catheter
to drainage of pericardial effusion before clamp the cord (Figure 3). Three
days later the rumor was removed on account of hemodynamic instability

Figure 1. Fetal echocardiographic image. (A, B): 2D imaging shows a mixed
echogenic mass arising from the wall of right atrium. Apparent pericardial
effusion is present; (C): Color flow imaging show slight obstructive inflow
of the right ventricle, but could not show blood flow in the mass.
RV, right ventricle; RA, right atrium; M, mass; PE, pericardial effusion.

(Figure 3). The hemangioma was confirmed by the pathologic examination
(Figure 4). In the follow-up, the male baby had normal cardiac structure and
function (Figure 3). Though this case, our aim is to investigate the sonographic
feather of a cardiac hemangioma and make prenatal diagnosis become possible.
Once a fetal cardiac hemangioma is suspected, tumer size, cardiac size, rhythm
disturbances, intra-cardiac masses leading to obstruction, extra-cardiac masses
and secondary effusions leading to tamponade and or fetal hydrops should be
checked periodically. Through fetal echocardiography one can gain insight
into the altered fetal pathophysiology that can occur during development,
which will allow for potential fetal intervention or preparation for postnatal
intervention. In addition, the cardiac surgery before clamp the cord is the
first case in China which is of certain value in the development of fetal cardiac
surgery.

Figure 2. Fetal magnetic resonance imaging (MRI). (A): MRI shows a mass
with a broad base of attachment arising from the wall of right atrium, that
with apparent pericardial effusion; (B): Slightly hypotensity on T1WI;
(C): Hyperintensity on T2WI.
RV, right ventricle; RA, right atrium; LV, left ventricle.

Figure 3. Postnatal echocardiographic image. (A): After Pericardiectomy;
(B): After right atrial mass resection.
RV, right ventricle; RA, right atrium; M, mass.

Figure 4. Right atrial mass. (A): Gross appearance; (B, C): Microscopic view.
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Elevated Serum Level of Interleukin-27, Interleukin-10 and
Interleukin-17A in Children with Kawasaki Disease
FF Si, RX Liu, Y Wu, F Gao, SQ Feng, QJ Yi
Children's Hospital of Chongqing Medical University, China
Background: Kawasaki disease (KD) arises due to the disorder of the
inflammation response and faulty immune regulation. Interleukin-27
(IL-27) is a novel cytokine with both pro-inflammatory and anti-inflammatory
effects. The relationship between IL-27 and KD is unexplored and in this
study we hypothesized that IL-27 is associated with the development of KD.
Methods: We obtained blood samples from 81 children with KD 24 hours
(h) before intravenous immunoglobulin (IVIG) therapy. For experimental
controls we also obtained blood samples from 20 children with an acute febrile
infectious disease (febrile control, FC) and 27 healthy children (healthy
control, HC). The serum levels of IL-27, Interleukin-17A (IL-17A) and
Interleukin-10 (IL-10) were measured using enzyme linked immunosorbent
(ELISA) assays.
Results: Patients with KD had higher serum levels of IL-27, IL-10 and
IL-17A compared with FC and HC groups. Serum levels of IL-27 were higher
in KD children diagnosed with coronary arterial lesions (CALs) than in
children with KD but without CALs. These results imply a strong positive
relationship between serum levels of IL-27, IL-10 and IL-17A in children
with KD.
Conclusion: Our results indicated that increased serum levels of IL-27 is
closely linked to the up-regulation of IL-10 and IL-17A in acute KD.
Additionally, our observation that IL-27 serum levels are even higher in
children with KD and CALs indicated that IL-27 may play an important role
in the development of CALs in acute KD.

The Rare Cause of Heart Failure in Children: Infantile Hepatic
Hemangioendothelioma
P Huang, L Zhang, MH Yu, XF Xie
Department of Pediatric Cardiology, Affiliated Guangzhou Women and
Children's Medical Center of Guangzhou Medical University, China
Objective: Infantile hepatic hemangioendothelioma is a rare tumor in children
and few can lead to congestive heart failure. This article summarizes the
clinical features, treatment and prognosis of infantile hepatic
hemangioendothelioma combined with congestive heart failure in children.
Methods: A retrospective analysis the clinical data of four children with
infantile hepatic hemangioendothelioma combined with congestive heart
failure in our institution from May 2013 to December 2015.
Results: Among four infants, 3 males and 1 female, mean aged of 86 days
(21-155 days), the average weight of 4350 g (2750-6500 g), 2 cases were
admitted because of abdominal swelling and respiratory distress, 1 case of
abdominal swelling, jaundice, shortness of breath admission, and 1 case of a
heart murmur, enlarged heart, and pulmonary hypertension. Two patients
were associated with hemangioma and Kasabach-Merritt syndrome. Three
cases were multiple liver hemangioma scattered in the left lobe and right
lobe of the liver, and one case was solitary liver hemangioma scattered in the
right lobe. Tumor size diameters were ranged from 2-10 mm. Four children
had been used prednisone (1-2 mg/kg.d) and digoxin, dopamine, furosemide,
spironolactone. Two cases were responded good to the therapy and followedup for 2 years and 1 and a half years respectively, whose heart size, heart
function and pulmonary hypertension became normal. One case with
Kasabach-Merritt syndrome responded poor to the therapy. Two cases were
experienced transcatheter hepatic arteriovenous fistula embolization, using
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coil occlusion of hepatic artery-venous fistula. The postoperative hepatic
tumor volume was significantly decreased, and the heart function is improved.
One patient was followed-up for 1 year and a half. The heart size, pulmonary
hypertension and heart function returned to normal. One case is still under
following-up. One case with Kasabach-Merritt syndrome was died from heart
failure and severe infection before surgery. The mortality rate was 25%.
Conclusions: Infantile hepatic hemangioendothelioma is a rare cause of
congestive heart failure in children. If heart failure is found unexplained in
children, it should be actively abdominal ultrasound or CT examination in
order to confirm the presence or absence of infantile hepatic
hemangioendothelioma. The mortality rate in infantile hepatic
hemangioendothelioma associated with congestive heart failure is very high.
Early identification, early intervention, especially prednisone combined with
transcatheter hepatic arteriovenous fistula embolization can significantly
improve heart function, reduce the mortality and improve the prognosis of
infantile hepatic hemangioendothelioma associated with congestive heart
failure in children.
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Permanent Pacing in a Premature Infant with Isolated Congenital
Complete Atrioventricular Block: A Case Report
YT Pertiwi,1 R Budi,2 C Achmad,1 R Sobarna,3 A Purnomowati,1 TM Aprami1
Department of Cardiology and Vascular Medicine, Universitas Padjadjaran;
2
Department of Pediatrics, Division of Pediatrics Cardiology, Universitas
Padjadjaran; 3Department of Surgery, Division of Thoracic and Vascular
Surgery, Universitas Padjadjaran, Indonesia

1

generator was implanted in a pocket made under at the anterior rectus sheath.
Surgery was performed without any complications. There was no respiratory
problem associated with pacemaker implantations in the abdominal wall. He
was discharged at the age of 31 days with a weight of 2350 g. At the 1-year
follow up he remains in well condition without any complications.
Conclusions: We have reported a case of a CCAVB with succesful
implantation of permanent pacemaker.

Introduction: Congenital complete atrioventricular block (CCAVB) is a rare
and potentially lethal disease with an estimated incidence of 1 in 15.000 to
20.000 live born infants. Most of the patients with CCAVB have structurally
normal hearts, referred to as an 'isolated' CCAVB.
Case Presentations: We present the case of a premature infant with CCAVB
who underwent implantation of a permanent pacemaker. The male infant
was born at 33 weeks of gestation and weighed 2150 g. Repeat fetal ultrasound
assessment before demonstrated fetal cardiomegaly increased at 30 weeks
gestation. The decision was made to deliver the baby by cesarean section at
33 0/7 weeks gestation. After birth, the infant showed respiratory distress
despite antenatal corticosteroid therapy. There were no clinical signs of
hydrops fetalis. The heart rate ranged between 40 and 50 bpm. An
electrocardiogram showed that the rate of P wave was 120 bpm and the rate
of QRS wave was 50 bpm. The chest x-ray demonstrated dilated heart and
echocardiogram showed dilated chambers, small non significant PDA with
left to right shunt, no ASD or VSD, and satisfactory contracted ventricles.
Respiratory problem was resolved after supportive treatment with temporary
pacing. He underwent successful implantation of a permanent transepicardial
pacemaker (VVIR mode, stimulation rate 120 bpm, output 1,5 mV and
sensitivity 2,6 mA). A unipolar epicardial lead was used and the pulse

Inhibition of Histone Acetylation by Curcumin Reduces Alcoholinduced Fetal Cardiac Apoptosis
XC Yan,1,2,3,4 B Pan,1,2,3,4 TW Lv,1 LJ Liu,1 XP Huang,5 J Tian1
Heart Centre, Children's Hospital of Chongqing Medical University, China;
2
Children's Hospital of Chongqing Medical University, Ministry of Education
Key Laboratory of Child Development and Disorders, China; 3 China
International Science and Technology Cooperation Base of Child
Development and Critical Disorders, China; 4Chongqing Key Laboratory of
Pediatrics, China; 5Department of Biomedical Science, Charlie E. Schmidt
College of Medicine, Florida Atlantic University, USA

1

Background: Prenatal alcohol exposure may cause cardiac development
defects. It is known that alcohol can induce cardiac apoptosis and myocardium
dysplasia, however the underlying mechanisms are not yet clear. Although,
our previous studies have suggested that histone modification plays a vital
role in alcohol induced fetal cardiac development abnormalities. This study
investigates the phenomenon further, particularly by examining the effect of
histone acetylation regulation mechanisms on alcohol induced cardiac
apoptosis.
Methods and Results: C57 pregnant mice were exposed of alcohol using
gavage. TUNEL assay revealed that positively stained cells were significantly
higher in the alcohol group. Western blotting revealed that alcohol increases
active-caspase-3 and active-caspase-8, whereas it reduces caspase-3, caspase8 and bcl-2. Furthermore, we observed that alcohol exposure enhanced
acetylation of histone H3K9 in embryonic hearts. ChIP assay showed that
alcohol significantly increased the acetylation of histone H3K9 in the promoter
of caspase-3 and caspase-8, and decreased the acetylation of histone H3K9
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in the promoter of bcl-2. Through in vitro experiments, we found that alcohol
treatment increased the expression of active-caspase-3, active-caspase-8 and
the acetylation of histone H3K9, and decreased the expression of caspase-3,
caspase-8 and bcl-2 in cardiac cells. Surprisingly, when we intervened cardiac
cells with curcumin the up-regulation of active-caspase-3, active-caspase-8
and acetylation of histone H3K9, and the down-regulation of caspase-3,
caspase-8 and bcl-2 were all reversed. Moreover, flow cytometry assay
demonstrated that the high apoptosis level that was induced by alcohol in
cardiac cells were down-regulated after curcumin treatment.
Conclusions: These findings indicate that histone modification may play an
important role in mediating alcohol induced fetal cardiac apoptosis, possibly
through the up-regulation of acetylation of H3K9 in the promoters of apoptosis
genes. This study also shows that curcumin may reverse alcohol-induced
fetal cardiac apoptosis, which provide further implications that curcumin is
protective against alcohol abuse during pregnancy.
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Pulmonary Nodules as an Uncommon Presentation in Kawasaki
Disease
L Zhang, XF Xie, ZP Wang, SL Xia, J Yuan, MH Yu
Pediatric Cardiology Ward, Guangzhou Women and Children's Medical
Center, China

X-ray on day 15 showed resolution of the pulmonary nodules. He was
discharged on day 21 in good clinical recovery. An echocardiogram on day
18 was normal, as were follow-up echocardiograms 1, 2, 4 and 6 months
after the acute stage of the disease.

A 2-year-old boy was admitted with a prolonged fever, bilateral bulbar
conjunctival injection without exudate, red lips and truncal rash. Amoxycillin
clavulonate had been prescribed without clinical response. Physical
examination on admission was significant for irritability and mild cervical,
epitrochlear, axillary, and inguinal lymphadenopathy. Laboratory studies
showed an elevated C-reactive protein, anemia, thrombocytosis, an elevated
erythrocyte sedimentation rate, sterile pyuria and normal liver enzymes.
Microbial cultures (blood, pharyngeal swab) were negative for pathogenic
specimens. Serologic tests for mycoplasma, chlamydia, cytomegalovirus,
Epstein-Barr virus, influenza, parainfluenza, adenovirus and enterovirus were
negative. Mantoux test, bone scan, bone marrow aspiration, rheumatoid factor,
antineutrophil antibody, antineutrophil cytoplasm antibodies, antinuclear
factor, and serum complements were negative or normal. Echocardiography
performed on day 8 of illness revealed left coronary arteries dilation without
aneurysms. Chest X-ray demonstrated bilaterally disseminated multiple
pulmonary nodules 6 mm in diameter and ground-glass alterations. A lung
CT scan showed numerous miliary nodules in diffuse and random distribution
in both lungs. The patient was diagnosed with incomplete KD, and was treated
with IVIG and aspirin. The infant was afebrile on day 14. A repeat chest

Another Reason of Giant Coronary Artery Aneurysm in
Children: Chronic Active Epstein-Barr Virus Infection
L Zhang, P Huang, ZP Wang, SL Xia, MH Yu, Y Xu, WG Hao
Department of Pediatric Cardiology, Affiliated Guangzhou Women and
Children's Medical Center of Guangzhou Medical College, China
Objective: To improve our understanding that chronic active Epstein-Barr
virus infection (CAEBV) may cause giant coronary artery aneurysm (GCAA).
Methods: To summarize and review the clinical data of a child with chronic
active Epstein-Barr virus infection (CAEBV) complicated by virus-associated
hemophagocytic syndrome and GCAA, Clinical features of similar cases from
published literatures were summarized. All literatures were retrieved
systematically.
Results: A 6-year-old Chinese girl was admitted to our hospital in March
2016 with an 18-day hepatosplenomegaly and 15-day fever history (up to
39.6°C). She also had a history of infectious mononucleosis sixteen months
ago and improved after treatment with intravenous gamma globulin and
ganciclovir. Physical examination on admission revealed marked
hepatosplenomegaly and lymphadenectasis, and laboratory examination
showed pancytopenia, liver dysfunction (alanine aminotransferase 105 U/L189 U/L) and coagulation dysfunction (APTT 88.4s-129.3s, Fib 0.99 g/L-1.8
g/L). Peripheral blood lymphocyte increased, atypical lymphocyte >10%.
VCA- IgM was negative, but other anti-EBV antibodies (VCA-IgG, EA-IgG
and EBNA) were positive. The EBV genome was clearly detected (6.47×103
cps/ml-3.72×104 cps/ml) in the peripheral blood by PCR analysis.
Transthoracic echocardiography showed giant right coronary artery aneurysm
(8.2 mm, RGCAA) and left coronary artery aneurysm (5.7 mm, LCAA). Bone
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marrow biopsies revealed infiltration of numerous macrophages engaged in
hemophagocytosis, clinically suggestive of CAEBV complicated by virus
associated hemophagocytic syndrome with RGCAA and LCAA. The patient
was treated with intravenous gamma globulin, ganciclovir, dexamethasone
and cyclosporine. The fever resolved on the 2th day of dexamethasone therapy,
but the hepatosplenomegaly and cervical lymphadenectasis persisted. On the
fourteenth day in the hospital, an echocardiography showed the similar
coronary artery change with no thrombosis.
Conclusions: (1) CAEBV may cause coronary lesion, especially giant
coronary artery aneurysm which might have potential for thromboembolism
and risk of acute myocardial infarction. (2) Once coronary artery lesions
occurred, the patient's history should be carefully investigated and are
classified according to risk strata. (3) Thrombolytic therapy is indicated when
blood coagulation return to normal in CAEBV patients.
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The Clinical Significance of ANCA in Kawasaki Disease
L Zhang, P Huang
Department of Pediatric Cardiology, Guangzhou Women and Children's
Medical Center, China
Objective: To investigate the clinical significance of anti-neutrophil
cytoplasmic antibody (ANCA) in patients with Kawasaki disease (KD).
Method: 472 patients with KD from January 1, 2014 to December 31, 2015
were divided into two groups according to the detection of ANCA, such as
positive group and native group. The positive rate of ANCA, the sensitivity
of intravenous immunoglobulin (IVIG) associated with ANCA and the
relationships of ANCA with coronary artery lesion degree were analyzed.
Results: The positive rate of ANCA in patients with KD was 23.3%; The
different of sensitivity to IVIG between positive group and negative group
was not statistically significant (P>0.05); Though the correlations between
coronary artery lesion and ANCA were not significant(X2=2.98, P=0.085,
r=0.073), the difference of coronary artery lesion degree between the two
group was statistically significant (P<0.05).
Conclusion: The positive rate of ANCA in patients with KD was low, and it
lack of predictability for the coronary artery lesions and sensitivity of IVIG,
and it is not as valuable as echocardiography to assess the degree of coronary
artery lesion. Therefore, the detection of ANCA in patients with KD is lack
of clinical significance.

Placental P-glycoprotein Inhibition Enhances Susceptibility to
Di(2-ethyhexyl)phthalate Induced Cardiac Malformations in
Mice
C Wang, KY Zhou, Y Zhang, YF Li, YM Hua
Department of Pediatric Cardiology, West China Second University Hospital,
Sichuan University, China
Backgrounds: P-glycoprotein (P-gp) forms a functional barrier between
maternal and fetal blood circulation in the placenta, thus protecting the fetus
from exposure to xenobiotics during pregnancy. Our previous study has proved
that maternal administration of Di (2-ethyhexyl) phthalate (DEHP, P-gp
substrate) in pregnant mice could result in various fetal cardiac malformations.
Purpose: This study aims to explore whether inhibition of placental P-gp
function with verapamil could enhance susceptibility to DEHP induced cardiac
malformations in mice or not.
Methods: The pregnant C57BL mice were randomized into the vehicle group
(n=10), the DEHP group (n=20, 1 g/Kg), the verapamil group (n=10, 3 mg/
Kg) and the DEHP+verapamil group (n=20). Pregnant dams in different
groups received respective interventions by gavage once daily from E6.5E14.5. Maternal weights were monitored every day and samples were
collected at E15.5. HE staining was used to examine fetal cardiac
malformations. Fetal cardiac development-related genes (Nkx2.5/Gata4/Tbx5/
Mef2c/Chf1) mRNA and protein expression were determined by quantitative
real-time PCR (qRT-PCR) and western blot (WB), respectively. Maternal
modality, maternal complete stillbirth/abortion rates and fetal cardiac
malformations rates were also calculated.
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Results: Maternal modality, maternal complete stillbirth/abortion rates and
fetal cardiac malformations rates of DEHP+verapamil group were
significantly higher than that of DEHP group, verapamil group and vehicle
group. Compared with DEHP group, verapamil group and vehicle group,
fetal cardiac Gata4/Mef2c/Chf1 expression was significantly down regulated
in DEHP+verapamil group. There were no differences in above parameters
between verapamil group and vehicle group.
Conclusions: Placental P-glycoprotein inhibition could enhance susceptibility
to DEHP induced cardiac malformations in mice.
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Implementing Transdisciplinary Approach to Cardiovascular
Disease
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Open University of Hong Kong; 2Tuen Mun Hospital, Hong Kong
Purpose: Despite efforts have been put in preventing and treating
cardiovascular disease, it is still one of the leading causes of high mortality
worldwide. To address the situation, a transdisciplinary approach is introduced
with the aim to address comprehensively the health hazard of cardiovascular
disease. The purpose of the current study is to explore the effectiveness of
adopting transdisciplinary approach to cardiovascular disease.
Methods: A systematic review was conducted to explore the effectiveness
of adopting transdisciplinary approach to cardiovascular disease. Multiple
databases were used to search the related articles. Data were categorized by
thematic analysis and presented.
Results: The results showed that a variety of disciplines with different
perspectives were collaborated in targeting cardiovascular diseases through
transdisciplinary approach. The effectiveness was supported in several aspects
including reducing the re-admission rate and enhancing the quality of life
among the patients. In addition, the health care organizations were also
benefited by better co-ordination of resources allocation, enhanced services
provided in cardiovascular diseases related areas, and foster research
collaboration among different disciplines.
Conclusion: Cardiovascular disease brings suffering to patients and cause
overwhelming financial burden. With the effectiveness of applying
transdisciplinary approach in treating cardiovascular disease for both patients
and health care organizations, this approach should be considered as a kind
of strategy in cardiovascular care.
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